Enumeration, Isolation, and Detection of Campylobacter species from Food Stuffs, Fecal Samples, and River Water of East Tennessee by West, Molly Albin
University of Tennessee, Knoxville 
Trace: Tennessee Research and Creative 
Exchange 
Doctoral Dissertations Graduate School 
8-2019 
Enumeration, Isolation, and Detection of Campylobacter species 
from Food Stuffs, Fecal Samples, and River Water of East 
Tennessee 
Molly Albin West 
University of Tennessee 
Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss 
Recommended Citation 
West, Molly Albin, "Enumeration, Isolation, and Detection of Campylobacter species from Food Stuffs, 
Fecal Samples, and River Water of East Tennessee. " PhD diss., University of Tennessee, 2019. 
https://trace.tennessee.edu/utk_graddiss/5630 
This Dissertation is brought to you for free and open access by the Graduate School at Trace: Tennessee Research 
and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator 
of Trace: Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu. 
 ENUMERATION, ISOLATION, AND DETECTION OF CAMPYLOBACTER SPECIES 
FROM FOOD STUFFS, FECAL SAMPLES, AND RIVER WATER OF EAST 
TENNESSEE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Dissertation Presented for the 
Doctor of Philosophy 
Degree 
The University of Tennessee, Knoxville 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Molly Albin West 
August 2019 
  
 ii 
Acknowledgement 
 From the bottom of my heart, thank you to every person who has encouraged, 
loved, reasoned, or answered a phone call throughout this degree. The following people 
have played an essential role in getting me to this moment. 
 I would like to thank my parents, David and Pam. I could have never made it to 
this day without you both telling me that I can do anything I put my mind to. Thank you 
for answering my calls and trying to understand my experiments, while teaching me 
more antibiotic classes than I could have dreamed. To my sister, Mallory, the tea towel 
you gave me years ago said it all, “proud of you.” To my in-laws, Jeff and Leslie, thank 
you for encouraging and loving me from day one. Your questions were always 
appreciated, especially when I’d work early mornings from your kitchen island. To my 
husband, Adam, I am forever grateful for your support through both graduate degrees, 
the bad semesters, early morning sampling trips, late nights studying or running PCR, 
and the many changes that came our way. 
 I am extremely grateful for the Department of Food Science and Herbert College 
of Agriculture. Dr. Morgan, thank you for the opportunities to lead and grow within this 
department. It was an honor and pleasure. Dean Beyl, you believed in me when I didn’t. 
I hope I have made you proud by keeping my promise to you…Dr. West is here! To Dr. 
White, thank you for supporting my project and pushing to get me done. Thank you for 
your contacts and aid when learning NARMS protocol. To Ms. Nancy, Ms. Connie, Ms. 
Davean, Ms. Ann, and Jessica – thank you for everything you ladies do for the 
department and all the laughs in Café Nancy. Lezlee Dice and Nathan Miller, you two 
are miracle workers and can troubleshot about any problem. We are all blessed to have 
 iii 
you as co-workers. Lastly, thank you to Rochelle and Julia at OIT for statistics 
assistance. 
 Thank you to my peers: Kemia Anders, Laurel Dunn, Melody Fagan, Stuart 
Gorman, Alexis Hamilton, Savannah Hawkins, Lindsay Jenkinson, Jourdan Jones, Katie 
Magee, Lindsay Murphy, Aubry Myers, Meredith Wayman, Mark Wenke, and Purni Wi. I 
am grateful for our friendships, especially when I needed to bounce a research idea, or I 
doubted my own knowledge. I appreciate all the hallway lunches and trips for ice cream. 
 To my committee members: thanks for sticking with me. Dr. John Buchanan, 
thank you for challenging me and my beliefs. Dr. Paul Erwin, thank you for believing in 
your 1st Food Science graduate student. I hope you’ve maintained your bowtie game at 
UAB. Dr. David Golden, you listened to me as a sophomore in undergrad trying to figure 
out what I wanted to be when I grew up and you continue to listen to me as I figure out 
what to do next and how-to adult. I appreciate you always being a call away and 
opening your home to me and Adam for many wonderful dinners. Our university, 
especially our students, is lucky to have you. Dr. Jennifer Richards, I am forever grateful 
that you believed in that young girl many years ago. I cannot imagine my education nor 
career without you. You have always been a call away and you continue to find ways to 
make me a better person, researcher, student, and professional. Dr. Faith Critzer, thank 
you for taking on a partial “Critzer Crew” student and for remaining a constant even 
hours away. You led me to a project I grew to love, while letting me do my own thing 
during these past three years. So, thank you!  
 
“To expect the unexpected shows a thoroughly modern intellect.” – Oscar Wilde 
 iv 
Dissertation Abstract 
Campylobacter species (spp.) are a leading cause of bacterial foodborne illness. 
These Gram-negative, microaerophilic microorganisms are found within the intestinal 
tracks of warm-blooded animals and in humans can cause gastroenteritis, 
campylobacteriosis. Recent outbreaks are linked to raw milk, water, and puppies; 
however, these outbreak isolates have expressed antibiotic resistance, a main 
treatment line for campylobacteriosis. While Campylobacter spp. detection improves, 
cases are mainly sporadic and largely underreported. East Tennessee counties 
experience a higher prevalence of campylobacteriosis compared to other regions of the 
state based upon Tennessee Department of Health (TDH) surveillance. It is important 
for researchers to explore the presence of Campylobacter spp. in the environment to 
help elucidate the high incidence of campylobacteriosis. This dissertation aimed to 
identify if Campylobacter spp. existed within the East Tennessee geographic region.  
The preliminary study collected samples (n=258) from local farmers’ markets, 
parks, processing facilities, and rivers to better understand possible vehicles for 
campylobacteriosis within the region. Following incubation, presumptive positive 
samples (n=46) were confirmed via PCR with targets for Campylobacter spp., C. jejuni, 
C. coli, and C. lari. Forty-two samples were confirmed as Campylobacter spp., twelve 
samples as C. coli, and two samples as C. jejuni. PCR confirmed isolates (n=39) were 
tested for antibiotic resistance. Eleven (28%) expressed resistance to antibiotics within 
the screening assay, according to the Clinical and Laboratory Standards Institute (CLSI) 
guidelines.  
 v 
A quantitative study collected samples (n=264) from four public access river sites 
to identify if Campylobacter spp. existed within river water throughout one calendar year 
within the Knoxville, Tennessee area. Following filtration and incubation, presumptive 
positives (n=244) were confirmed via PCR with targets for Campylobacter spp., C. 
jejuni, C. coli, and C. lari. Confirmed isolates were identified as Campylobacter spp. 
(n=168) and C. coli (n=5). PCR confirmed samples (n=161) were tested for antibiotic 
resistance amongst a panel of eight antibiotics. Ninety-five (59%) isolates expressed 
resistance, according to CLSI guidelines. 
By completing this study, a need to update campylobacteriosis risk factors, 
prevention education, and future treatment options has been identified, especially 
among TDH surveillance areas.  
 vi 
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Dissertation Organization 
 
This dissertation is organized as follows. 
Introduction lays out a brief overview of Campylobacter, its incidence, and the 
research conducted for this dissertation. Chapter I introduces Campylobacter in detail, 
provides a background on previous Campylobacter related outbreaks and research, and 
presents a need for additional Campylobacter research. Chapter II provides a brief 
Campylobacter review and information on previous Campylobacter related outbreaks 
and research involving produce, livestock animals, birds, and water. Additionally, 
Chapter II presents a preliminary study on the regional presence of Campylobacter 
species. Chapter III reviews Campylobacter, provides information on previous 
waterborne Campylobacter related outbreaks and research, and presents a study on 
the presence of Campylobacter species within regional waterways. 
Introduction 
Campylobacter species (Campylobacter spp.) are a leading cause of bacterial 
foodborne illness. Campylobacter spp. are Gram-negative, microaerophilic 
microorganisms found within the intestinal tracks of warm-blooded animals and can 
cause gastroenteritis in humans. Currently, there are 27 known species of 
Campylobacter, with three most commonly associated with campylobacteriosis in 
humans. Surveillance began in 1982 yielding 57 outbreaks from 1978 to 1986 (45 food, 
11 water, and one unidentifiable) and 262 outbreaks from 1997 to 2008 (225 food, 24 
water, 7 animal, and 6 unidentifiable). More recently, outbreaks have been linked to raw 
milk, contaminated water, and puppies; however, more importantly these outbreak 
isolates have expressed antibiotic resistance, a main treatment line for 
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campylobacteriosis. Campylobacter contain many virulence factors – secretion systems, 
a capsule, flagellum, cytolethal distending toxin (CDT), adhesions, and 
lipopolysaccharides (LPS) – that allow for survival in the environment. While 
Campylobacter spp. detection improves, cases are mainly sporadic and largely 
underreported with growing antibiotic resistance. East Tennessee counties experience a 
higher prevalence of campylobacteriosis compared to other regions of the state based 
upon Tennessee Department of Health (TDH) surveillance. It is important for 
researchers to explore the presence of Campylobacter spp. in the environment to help 
elucidate the high incidence of campylobacteriosis.  
This study aimed to identify if Campylobacter spp. exist within food stuffs, animal 
feces, and river water from East Tennessee to better understand possible vehicles for 
campylobacteriosis within the region. From March through August 2017, samples 
(n=258) were collected from local farmers’ markets, parks, processing facilities, and 
rivers.  A food or fecal sample was diluted and incubated at 37˚C for 4 h then 44 h at 
42˚C in a microaerophilic environment (5% O2, 10% CO2, 85% N2). Water samples were 
vacuum filtered through a 0.45μm membrane filter. Samples were plated onto Campy 
CHROMagar® and incubated in a microaerophilic environment for 4 h at 37˚C then 44 h 
at 42˚C for isolation of Campylobacter. All presumptive positive samples (n=46) were 
confirmed via PCR with targets for Campylobacter spp., C. jejuni, C. coli, and C. lari. 
Forty-two samples were confirmed as Campylobacter spp. – microgreens (n=5/5; 
100%), sprouts (n=2/3; 66%), Tennessee River water (n=8/8; 100%), Hiwassee River 
water (n=6/7; 86%), cattle feces (n=5/6; 86%), swine feces (n=12/13; 92%), and geese 
feces (n=4/4; 100%). Twelve pork fecal samples were confirmed as C. coli and one 
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goose and one cattle fecal sample as C. jejuni. PCR confirmed isolates (n=39) were 
tested for antibiotic resistance. Twenty isolates expressed no growth and nineteen 
isolates were susceptible to antibiotics, 9 expressed intermediate conditions, and eleven 
expressed resistance to antibiotics within the screening assay, according to the Clinical 
and Laboratory Standards Institute (CLSI) guidelines.  
The second part of this study aimed to better understand the spatiotemporal 
distribution of Campylobacter spp. and further elucidate surface water as a possible 
vehicle for campylobacteriosis by sampling multiple sites of the Tennessee River. 
Samples (n=264) were collected from four public access river sites throughout East 
Tennessee for one calendar year (November 2017-November 2018).  Water samples 
were vacuum filtered through a 0.45μm membrane filter. Filters were plated onto Campy 
CHROMagar and incubated at 37˚C for 4h then 42˚C for 44h in a microaerophilic 
environment (5% O2, 10% CO2, 85% N2). Presumptive positives (n=244) were 
confirmed via PCR with targets for Campylobacter spp., C. jejuni, C. coli, and C. lari. 
Confirmed isolates were identified as Campylobacter spp. (n=168) and C. coli (n=5). All 
collection sites had relatively high levels of Campylobacter spp. isolated [site A 
(n=30/38; 79%), site B (n=29/38; 76%), site C (n=77/132; 58%), and site D (n=32/36; 
89%)]. Five water samples were confirmed as C. coli from site D, which were obtained 
from January to March. PCR confirmed samples (n=161) were tested for antibiotic 
resistance amongst a panel of eight antibiotics. Ninety-five (59%) isolates expressed 
resistance, of which 23 (14%) isolates were resistant to one antibiotic, 27 (17%) isolates 
were resistant to two, 18 (11%) were resistant to three, 12 (7%) were resistant to four, 
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three (2%) were resistant to five, four (2%) were resistant to six, and five (3%) were 
resistant to seven, and three (2%) were resistant to all eight.  
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Chapter I: Campylobacter: A leading foodborne pathogen largely still 
unknown – A review  
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Abstract 
 Campylobacter species are a leading cause of bacterial foodborne illness. 
Campylobacter spp. are Gram-negative, microaerophilic organisms found within the 
intestinal tracks of warm-blooded animals and can cause gastroenteritis in humans. 
Originally classified as a Vibrio spp., there are 27 species of Campylobacter with three 
most commonly associated with campylobacteriosis. Surveillance began in 1982 
yielding 57 outbreaks from 1978 to 1986 (45 food, 11 water, and one unidentifiable) and 
262 outbreaks from 1997 to 2008 (225 food, 24 water, 7 animal, and 6 unidentifiable). 
More recently, outbreaks have been linked to raw milk, contaminated water, and 
puppies; however, more importantly these outbreak isolates have expressed antibiotic 
resistance, a main treatment line for campylobacteriosis. Campylobacter contain many 
virulence factors – secretion systems, a capsule, flagellum, cytolethal distending toxin 
(CDT), adhesions, and lipopolysaccharides (LPS) – that allow for survival in the 
environment. While Campylobacter spp. detection improves, cases are still majority 
sporadic and significantly underreported with growing antibiotic resistance. It is 
important for researchers to explore the presence of Campylobacter spp. in the 
environment to help elucidate the high incidence of campylobacteriosis.    
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Introduction  
Campylobacter  
Previously classified as Vibrio species and once known to be a cause of 
veterinary spontaneous abortions, Campylobacter species (spp) are microaerophilic, 
Gram-negative, curved rods with a single, polar flagellum (17, 46). In the 1950s, 
Campylobacter spp. were first identified from human blood cultures, which researchers 
believed to be uncommon, opportunistic pathogens. These early detected pathogenic 
microorganisms were classified as Vibrio fetus and related Vibrio (46). 
In 1978, Bennington, Vermont had one-fifth (n=2000) of its community suffering 
from abdominal pain or cramps and diarrhea, followed by malaise, headache, and fever. 
Consumption of the municipality’s water was found to be significantly correlated with 
illness (p < 0.005). Epidemiologists identified that, while the city chlorinated its main 
water supply, it was not filtered. Additionally, while the water line in use required 
chlorine, collected water samples did not show residual chlorine. Of nine cases sent for 
testing, five had positive rectal swabs cultured at the Centers for Disease Control and 
Prevention (CDC) for Campylobacter fetus. This resulted in the first known 
Campylobacter spp. outbreak in the United States (48). 
Campylobacter spp. are naturally occurring microorganisms within the normal 
intestinal microflora of warm-blooded animals and are commonly associated with birds 
allowing for easy entrance into the environment by defecation of these hosts (2). They 
are a leading cause of an acute diarrheal illness known as campylobacteriosis, which 
can lead to abdominal pain, cramps, diarrhea, malaise, headache, or fever. In the most 
severe cases, bloody stool mirroring ulcerative colitis might be experienced (17, 57). 
Typically, symptoms are expressed 24-48 hours after consumption, but this varies 
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based on many factors, such as immune status, age, and number of organisms 
consumed (21). Symptoms can last from 2-7 days, but a person might shed the 
microorganism for months following the cessation of symptoms (17).  
There are an estimated 9.4 million cases of foodborne illness, in the U.S., from 
31 known pathogens annually, which result in 55,961 hospitalizations and 1,351 deaths, 
yet most foodborne illnesses are not detected or reported to health officials (38). In 
2016, Campylobacter had the highest incidence of confirmed cases with 11.79 cases 
per 100,000 persons and 17.43 culture-independent diagnostic tests (CIDTs) confirmed 
cases per 100,000 persons according to the annual Foodborne Diseases Active 
Surveillance Network (FoodNet) progress report (27). However, FoodNet reports 99% of 
all Campylobacter cases are sporadic meaning they are not recognized to have an 
epidemiological link to an outbreak (47). 
Campylobacter species 
 In 1963, Sebald and Veron suggested a new genus, Campylobacter, for these 
Vibrio-like organisms leading to the change of Vibrio fetus (V. fetus) and Vibrio bubulus 
(V. bubulus) to Campylobacter fetus (C. fetus) and Campylobacter bubulus (C. 
bubulus). In the mid 1970’s, researchers advocated for four species – fetus, coli, jejuni, 
and sputorum (51). Fetus represented the type of species, coli was for swine isolates, 
and jejuni for cattle, human, or sheep isolates. Sputorum was divided into two 
subspecies – sputorum and bubulus (33). Sputorum represented isolates collected from 
the sputum first seen in a bronchitis patient (36, 49) and bubulus those from “vaginal 
and preputial secretions, sperm, fetuses, and fetal membranes” (51). As research and 
interest grew, the number of Campylobacter spp. and detection methodologies became 
established.  
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 Currently, there are 27 species (Table 1.1) and eight subspecies of 
Campylobacter with Campylobacter jejuni (C. jejuni) serving as the species of greatest 
concern causing most of the campylobacteriosis cases worldwide (17, 26, 33).  
While not the main cause of campylobacteriosis, C. fetus was the first species to 
be identified. C. fetus subsp. fetus was initially associated with spontaneous abortions in 
sheep and cattle (29). C. fetus subsp. venerealis was associated with bovine genital 
campylobacteriosis leading to infertility, abortion, and embryonic death. The two species 
which cause the majority of foodborne illnesses are C. jejuni and C. coli. Originally, 
these two species were isolated from the stool of cattle and pigs. They differ in the 
hydrolysis of sodium hippurate, for which C. jejuni are positive (12, 40). Another species 
of concern for humans, C. lari, are associated with human bacteremia and diarrhea, 
especially in immune-deficient patients. Key phenotypic differences amongst C. lari, C. 
jejuni and C. coli are 1) an inability to hydrolyze indoxyl acetate and 2) nalidixic acid 
resistance (18, 33, 37). Currently, any Campylobacter strain that can produce urease, is 
susceptible to nalidixic acid, or can both produce urease and is susceptible to nalidixic 
acid are considered C. lari (33, 37). 
 In addition to pathogenic Campylobacter spp., there are some species found 
naturally occurring within the human oral cavity. These species are as follows: C. 
concisus, C. carvus, C. showae, C. rectus, and C. gracilis. Tanner et al. (45) studied 
multiple C. rectus, C. concisus, and C. gracilis strains extracted from periodontal 
pockets to understand characteristic similarities and differences. Researchers 
concluded that while similar, C. rectus have a smaller molecular weight than C. 
concisus and C. gracilis (45). C. ureolyticus formerly Bacteroides ureolyticus have been 
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extracted from genital, dental, and soft-tissue sites (19). C. gracilis formerly Bacteroides 
gracilis have been associated with head, neck, and lung infections (19). C. upsaliensis 
have been found in bacteremic humans, human abscesses, and abortion cases (22, 
33). While C. hominis have been detected in healthy humans, diarrheic humans, and 
otherwise healthy humans, can also test positive for C. lanienae, if they work in meat 
processing facilities since they are associated with seemingly healthy swine (22, 25, 
33). 
A Snapshot of USA Campylobacter Outbreaks and History of Detection  
 Epidemiologist considered Campylobacter spp. to be the primary cause of 
abortions in animals without any links to impact on public health until the 1978 outbreak 
in Bennington, VT. Less than one month later, a small outbreak in Colorado linked to C. 
fetus subsp. jejuni occurred within a farming family. Of the five family members, three 
experienced malaise, muscle pain, and nausea with one family member experiencing 
bloody diarrhea (4). Cases were treated with erythromycin and stool cultures were 
collected from cases, non-ill family members, and farm animals (chickens, swine, 
sheep, calves, and a cow). Fecal samples from non-ill family members, chickens, swine, 
sheep, and calves were negative; however, fecal samples from all cases and the cow 
were positive for C. fetus subsp. jejuni. It was identified that all three cases reported 
drinking raw cow’s milk (4). 
 In 1982, laboratory surveillance of Campylobacter began in 11 states which 
already had surveillance programs for Salmonella and Shigella. As states began 
Campylobacter surveillance, the national incidence rate increased; however, the 
incidence rate remained proportional to the national population, meaning the increase 
was caused by new surveillance and not an increase in cases. Through surveillance, 57 
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outbreaks were identified from 1978-1986 involving Campylobacter spp. related to water 
(n=11), food (n=45), and one unidentified (n=1) (46). This yielded 41,343 isolates 
(n=3,630 non-reported) with 99% (n=37,478) of outbreaks due to C. jejuni followed by 
C. fetus (0.4%), C. coli (0.2%), C. laridis (0.02%), C. sputorium (0.003%), C. faecalis 
(0.003%), and a Campylobacter-like organism (0.003%) (46). At that time, researchers 
saw a bimodal peak of illness in May and October, with difficulty isolating 
Campylobacter spp. in warmer months from environmental samples (46). 
Taylor et al. (47) evaluated common source outbreaks from 1997 to 2008, in 
which Campylobacter spp. were the causative agent. Researchers reviewed a total of 
262 outbreaks, 9,135 illnesses, 159 hospitalizations, and three deaths related to 
campylobacteriosis. As a nation, the United States averaged 16 outbreaks annually 
from 1997-2002, increasing to 28 from 2003-2008, with the majority occurring in warmer 
months. Taylor et al. (47) reported that while raw milk had been historically the most 
common outbreak source, two of the three deaths were related to a single outbreak of 
contaminated water. Of the 262 reported outbreaks, dairy products were linked to 65 
outbreaks (24.8%), followed by poultry (n=25 or 9.5%), and produce (n=12 or 4.6%). 
Additionally, the majority of Campylobacter outbreaks occurred during summer months 
with 128 occurring from May-August of 2005-2008. The three largest outbreaks were 
reported during warmer months, one foodborne (n=1,644) and two waterborne 
(n=1,450, n=781) (23). While raw milk and poultry are a primary focus when evaluating 
risk of Campylobacter, water is a routinely identified vehicle either causing illness 
through interaction with contaminated potable or recreational water. In 2017, C. jejuni 
was associated with an outbreak attributed to municipal water which was contaminated 
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from an adjacent concentrated animal feeding operation (CAFO) runoff into the area 
surrounding two wells that supplied water to the city (34). 
The CDC reviewed outbreaks related to unpasteurized or raw milk from 2007-
2012. Over six years, a reported 81 outbreaks were reported from 26 states that 
resulted in 979 illnesses, 73 hospitalizations, and zero deaths (32). Determining a single 
causative agent is not always feasible, but 78 of these 81 outbreaks had an identifiable 
etiological pathogen. The CDC determined that 81% (n=62) of these outbreaks were 
caused by Campylobacter spp. (32). The US averaged 3.3 raw milk outbreaks from 
1993-2006; however, from 2007-2012, the US averaged 13.5 outbreaks (32). One of 
those occurred in 2011, when Alaskan public health officials identified a cluster of 
matching pulsed-field gel electrophoresis (PFGE) Campylobacter isolates. Following an 
investigation, seven residents were identified as consuming raw milk from a local herd 
share program in the Matanuska-Susitna Valley (41). Additionally, in 2013, there was a 
large-scale outbreak within the Kenai Peninsula of Alaska due to raw milk consumption. 
Epidemiologists identified over 30 cases ranging from 7 months of age to 72 years old 
testing positive for C. coli infection due to a herd share program. Two cases were 
hospitalized and four developed reactive arthritis (42). In 2014, there were two separate 
outbreaks related to raw milk consumption. The first occurred in Utah, where the sale of 
raw milk is legal with a Utah Department of Agriculture and Food permit. Following 
routine monthly testing, the dairy’s products tested within the acceptable levels. It was 
not until “enhanced testing procedures recovered C. jejuni” following a cluster of 
campylobacteriosis cases reported to the health department (11). From May to 
November 2014, ninety-nine cases were identified, and the dairy’s permit was revoked 
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(11). The second raw milk outbreak occurred in Wisconsin following a team dinner 
where raw milk was served as a beverage. Wisconsin health officials tested fecal 
samples from the dairy, which tested positive to the same Campylobacter strain in the 
22 cases (35).  
Campylobacter spp. are rarely identified as a biological hazard for fruits and 
vegetables. However, there have been some well documented outbreaks associated 
with produce, demonstrating the ability of Campylobacter spp. to survive within this 
environment (8). In a recently completed meta-analysis of Campylobacter spp. 
prevalence in fresh fruits and vegetables, the prevalence of contamination was 
estimated to be 0.53% amongst fresh produce (30). Bean and sprouts were found to 
have the highest reported prevalence (11.08%) (30).  
Doyle and Schoeni (12) identified that while rare, fresh produce, specifically ones 
packaged in a polyvinyl chloride film-wrap can serve as a vehicle for 
campylobacteriosis. They found C. jejuni contamination within 1.5% (n=200) of retail 
mushrooms; however, contamination was not likely caused by compost due to its heat 
treatment. Their next hypothesis was the peat and lime casing material in addition to the 
moist growth environment aided in the survival of C. jejuni. These wrapped mushrooms, 
while held at refrigeration temperatures, are packaged in a low oxygen environment, 
which allows for the survival of this microaerophilic pathogen (12).  
While the vast majority of outbreaks are linked to milk and poultry products, 
increasing evidence can be found that Campylobacter spp. may have greater tolerance 
to the environment than first thought, considering it shows little tolerance to common 
environmental stressors. When evaluating the adaption of C. jejuni to the phyllosphere 
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and rhizosphere of radishes and spinach, populations declined in all temperatures, but 
cooler temperatures of 10ºC and 16ºC allowed for survival up to 28 days in the 
rhizosphere of these crops (6). The ability to survive in the soil and water for increased 
periods of time may help persistence and spread to typical warm-blooded hosts.   
In recent years, outbreaks have been related to a variety of sources ranging from 
raw milk to contaminated water at an obstacle course race. In 2012, twenty-two cases 
were identified as having a C. coli infection following participation in a long-distance 
obstacle adventure race in Nevada. Epidemiologists were able to identify a strong 
association (OR=19.4; p<0.001) between the consumption of mud while competing in 
the race and campylobacteriosis (58). This outbreak brought awareness to 
Campylobacter spp. capability to survive in low-oxygen environments without a warm-
blooded host, which could further explain sporadic cases or those without an 
epidemiologic link to a known outbreak. 
Although significant decreases in the prevalence of many pathogens have been 
observed over time, incidence rates of Campylobacter spp. associated-infections have 
continued to climb.  There was a 12% increase in the incidence rate of 
campylobacteriosis for 2018 when compared to 2015-2017 FoodNet data (44). This 
points to the continued need to investigate and uncover sources of contamination and 
methods for improved control within food systems.  
Campylobacteriosis Treatment and Sequelae 
 Traditionally, campylobacteriosis is treated with fluids or oral antibiotics. 
Antibiotics are classified into over 20 classes to which each individual antibiotic is 
identified as either bactericidal or bacteriostatic. Bactericidal antibiotics kill the bacteria, 
while bacteriostatic antibiotics halt the growth and allow the immune system time to 
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attack and inactivate the bacteria. Antibiotics are also classified by their mechanism of 
action: cell wall synthesis, protein synthesis, DNA synthesis, RNA synthesis, folate 
synthesis, or combinations. Penicillin and cephalosporin classes inhibit bacterial cell 
wall synthesis by inhibiting transpeptidase. Macrolides and tetracyclines are 
bacteriostatic, while aminoglycosides are bactericidal; however, these three classes all 
inhibit protein synthesis. Fluoro/quinolones block DNA synthesis by binding DNA gyrase 
(52). Campylobacteriosis is commonly treated with erythromycin (a macrolide), 
tetracycline, or ciprofloxacin, which is a fluoro/quinolone (39).  
As Campylobacter spp. continue to be a leading cause of bacterial foodborne 
illness, researchers continue to investigate antibiotic resistance and sensitivity. In 1999, 
researchers in Minnesota reviewed Campylobacter isolates submitted to the state 
laboratory from 1992 to 1998. These years were investigated since fluoro/quinolones 
were not approved for use within the poultry industry until 1995 and investigators aimed 
to identify if there was a change in quinolone- or nalidixic acid-resistant isolates after the 
release of this antibiotic class into the poultry industry. Researchers found there was an 
increase in quinolone-resistant isolates from 1.3% to 10.2%; however, most cases were 
linked to international travel or taking quinolones preventatively while traveling or upon 
return. Similarly, researchers in Spain, Taiwan, and the United Kingdom found an 
increase in quinolone-resistant Campylobacter isolates following the release of 
fluoroquinolones for use within the poultry industry (39). 
 In 1996, the CDC began the National Antimicrobial Resistance Monitoring 
System-Enteric Bacteria (NARMS) and in 2003 it went nationwide. NARMS aims to 
monitor “antimicrobial resistance among enteric bacteria from three sources: humans, 
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retail meats, and food animals” (10). Since 2016, several noteworthy outbreaks 
associated with Campylobacter spp. exhibiting resistance to multiple antibiotics have 
occurred.  
The first occurred in early August until October of 2016 due to the consumption 
of raw milk in Colorado. While raw milk sales are illegal in Colorado, herd share 
programs are permitted. Due to a lack of assistance by the herd share program, state 
public health officials issued a notice leading to the participation of 91 shareholder 
households in a follow-up interview. From interviews, twelve confirmed cases and five 
probable cases were identified ranging in age from 12-68 years yielding one 
hospitalization and zero deaths. PFGE was available for ten cases and four milk 
samples for C. jejuni. All PFGE confirmed case isolates and two milk isolates were sent 
to NARMS for antimicrobial testing. NARMS tested five isolates, of which all were 
ciprofloxacin-, tetracycline-, and nalidixic acid-resistant (7).  
The second reached national news in 2017 when an outbreak of Campylobacter 
related to puppies found at pet stores reached 18 states and had a total of 118 cases. 
During this outbreak, 105 cases reported a dog exposure of which 95% reported contact 
with a puppy from a pet store and eight reported contact or purchasing a puppy from an 
additional pet store. While less than 25% of cases (n=26) were hospitalized and there 
were no identified deaths, this outbreak brought attention to a notable level of antibiotic 
treatment within the commercial dog industry for two reasons: (1) types of antibiotics 
used and (2) widespread antibiotic resistance. After a review of 149 pet store puppy 
records, puppies received prophylactic treatment (n=78), antibacterial treatment (n=2), 
or both prophylactic and antibacterial treatment (n=54). Broad spectrum antibiotics, 
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such as doxycycline and azithromycin, accounted for 81% of dispensed antibiotics in 
addition to the use of veterinary antibiotics, such as sulfadimethoxine.  
Human (n=45) and puppy (n=11) C. jejuni isolates were tested via whole-genome 
multilocus sequence typing. Three clades were found with two containing ≤32 
genetically different alleles and one with ≤30 genetically different alleles. There were 18 
isolates matched to all three clades that were additionally tested. All eighteen isolates 
were resistant to the following antibiotics: azithromycin, ciprofloxacin, clindamycin, 
erythromycin, nalidixic acid, telithromycin, tetracycline, and some samples resistant to 
gentamicin and florfenicol (31). These antibiotics represent the main treatment lines for 
patients, clearly impacting efficacy of any medical interventions (9). As antibiotic 
resistance rises, cases can experience longer disease duration or treatment 
complications without the invention of newer antibiotics, which can result in economic 
losses and potential health effects from post-infectious secondary illnesses or sequelae.  
Campylobacteriosis sequelae 
 Following campylobacteriosis, individuals are known to experience various 
sequelae, including Guillain-Barré syndrome (GBS), reactive arthritis (ReA) or Reiter’s 
Syndrome, and irritable bowel syndrome (IBS). The World Health Organization (WHO) 
reports one-third of GBS cases are associated with campylobacteriosis and another 
third of patients will develop GBS within two years (53). GBS is a neurological disorder 
caused by the immune system attacking the peripheral nervous system leading to 
weakness, an inability to breathe, and paralysis. Most cases recover with some 
experiencing varying degrees of weakness. Currently, acute and rehabilitative therapies 
are available for GBS cases; however, in 2013, van den Berg et al. (50) reported 3-7% 
  
 
18 
death due to GBS complications (53). Unlike GBS, ReA and IBS have a less formal 
diagnostic process and are still being fully understood.  
 Reactive arthritis (ReA) or Reiter’s Syndrome is an acute arthritis triggered by a 
gut, genital, or urinary tract infection (15, 16). In 1981, Gumpel et al. (15) identified 
seventy-seven Campylobacter positive human stool samples outside London, England. 
Of these 77 cases, 47 were hospitalized with 33 of the hospitalized cases being 16 
years of age or older. After reviewing cases over 16 years of age, eight were identified 
as experiencing a possible ReA episode and two sought medical treatment. Of these 
two cases, one was a 30-year-old woman with a swollen wrist, two swollen knees, a 
tender toe joint, and an arthritic neck. All of her symptoms followed an episode of 
excessive watery diarrhea (15). Her condition resolved itself over a 6-month timeframe 
and she tested negative for HLA B27, an antigen believed to be involved in ReA. The 
second involved a middle-aged man with a swollen knee following a 6-week spell of 
diarrhea and cramping. While widespread calcium crystals were found on his joints, his 
synovial fluid was sterile (15). This study aimed to estimate the frequency of ReA 
associated with positive Campylobacter spp. diarrhea due to an assumption of ReA and 
campylobacteriosis being an additional cause of ReA, similar to salmonellosis (15). 
Hannu et al. (16) evaluated Campylobacter positive cases from April 1997 to September 
1998 in Finland. Cases were matched by age, sex, and location to controls to identify 
arthritis symptoms after campylobacteriosis. A total of 405 matched pairs were 
interviewed with 38% (n=220 of 582) Campylobacter positive cases reporting ReA 
versus Campylobacter negative controls reporting 24% (n=185 of 758). Of the 220 ReA 
controls, 113 were clinically examined of which 45 were diagnosed as experiencing 
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ReA. Similar to Gumpel et al. (15), cases in this study most commonly reported 
inflammation of the knees (16), 
 IBS or “a chronic, episodic medical condition associated with abdominal pain or 
discomfort and altered bowel habits,” is estimated to develop in 4-32% of bacterial 
gastroenteritis cases (13). In a 2013 study by Sung et al. (43), rats were injected with 
100 million C. jejuni cells in three populations – juvenile only, adult only, or both juvenile 
and adult rats. Following incubation, researchers identified rats with a previous injection 
of C. jejuni recovered quicker than those who had not. Adult rats had a shorter duration 
than juvenile ones, and most juvenile rats had cleared an infection by adulthood. 
Additionally, researchers noticed small intestinal bacterial overgrowth (SIBO), which is 
assumed to be a contributing symptom of IBS. Of the rats (n=49) infected as both 
juvenile and adult, 47% developed SIBO while only 26% of adult only (n=50) infected 
rats developed SIBO. Results from this study reflected previous epidemiologic findings 
that immunity can be acquired, and post-infection IBS can develop following repeated 
infections (43).  
 
Campylobacter virulence factors 
 Pathogenic microorganisms acquire virulence factors as a mechanism of 
protection against a host’s immune system or for survival within a new environment in 
order to cause infection within another host. Campylobacter spp. are competent 
pathogens meaning they have the ability to uptake DNA from their environment by in 
vitro or host colonization (55). Campylobacter spp. DNA uptake is driven by the use of 
carbon dioxide and bacterial cell density (55). C. jejuni use transposon mutagenesis or 
the ability to transfer genes to the host’s chromosomes to enter competence. 
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Campylobacter spp. have the following virulence factors: secretion systems, capsule, 
flagellum, toxin, adhesions, and lipopolysaccharides (55). 
Secretion Systems 
 Campylobacter spp. secretion systems are still being researched, but the role of 
protein CiaB has been elucidated. CiaB allows for Campylobacter spp. to affectively 
invade host epithelial cells. During a chicken study, mutant strains were not capable of 
host colonization allowing researchers to better understand its importance. 
Campylobacter spp. express a Type III secretion system utilizing CiaB proteins through 
the flagella by excreting itself as FlaC. These proteins are necessary following host cell 
contact allowing the Type III secretion needle to inject pathogenic material into the host 
cell (21, 52). Additionally, Campylobacter spp. are capable of moving proteins from the 
inner membrane to the outer membrane by the flagella allowing for infection of 
additional cells, mimicking a Type II and Type IV secretion system (55). Recent 
research by Bleukmik-Pluym et al. (5) identified a Type VI secretion system within 
certain C. jejuni strains due to the presence of T6SS genes, hcp and vgrG, following 
whole genome sequencing. By expressing a working T6SS, Campylobacter have the 
ability to attached and infect host cells and survive in the presence of bile salts, which 
aim to eliminate waste from the body (24). 
Capsule 
 Campylobacter spp. express a capsule, which allows for intestinal cell adherence 
and invasion, prolonged infection in vivo during mouse studies, and resistance to 
human serums (28, 55). Capsule composition varies by species, but it contains sugars, 
like heptose and xylose, not traditionally associated with bacterial capsules. 
Traditionally, bacterial capsules are comprised of glycoproteins, polypeptides, and D-
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glutamic acids. Researchers attribute capsule variety to phase variation instead of 
species mutations (55). 
Flagellum 
 Campylobacter spp. express a single, polar flagellum, which is used for the 
colonization and invasion of host cells and movement allowing the pathogen to survive 
(14, 55). The flagellum is comprised of a basal body, hook, and filament (20). The 
filament contains FlaA, a major flagellin, and FlaB, a minor flagellin (14, 20). Flagella 
with mutated flaA expressed decreased motility, while mutated flaB did not express a 
significant decrease in motility (14). In a study by Black et al. (3), adults (n=111) were 
infected with various dosages of C. jejuni strains to better understand motility. 
Researchers found that while all collected fecal samples contained leukocytes, only 
those infected with motile strains were identified within fecal samples (3). The flagella 
have no secretion systems, but utilize three secretion proteins, Cia, FlaC, and FspA. Cia 
is found in three Campylobacter spp. (C. coli, C. upsaliensis, and C. lari) and require a 
basic flagella structure to aid in motility and host cell invasion (14). FlaC protein is not a 
part of the filament nor required for motility but can extend as far as the hook portion 
(14). The final secretion protein, FspA, is specific to C. jejuni and has multiple forms, but 
only FspA2 is “toxic to eukaryotic cells” (14). Campylobacter flagella have toll-like 
receptor 5 (TRL5). TLR5 recognizes the amino and carobxy conserved regions of the 
flagellins, which prevents host cell innate immune system response. Finally, 
Campylobacter flagella are glycosylated, which was once believed to only occur in 
eukaryotes; however, C. jejuni are incapable of building a flagellum if the filament is not 
glycosylated (14). Glycosylated surface structures allow for protection against immune 
system response by utilizing antigenic variation (21). 
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Cytolethal Distending Toxin (CDT) 
 Cytolethal distending toxin is made up of three proteins, which form a complex – 
CdtA, CdtB, and Cdt – used to take up host cells leading to cell death by preventing cell 
division (1, 55). CdtA and CdtC are structurally similar and bind HeLa cells causing 
endocytosis of ricin allowing CdtB to perform. CdtB performs similar to a DNAse by 
colonizing the host cell’s nucleus leading to DNA damage and the signaling of DNA-
repair proteins (1, 55). In a mouse model using Helicobacter hepaticus and C. jejuni, 
wild-type mice were colonized by CDT. Mutant-mice without a nuclear-factor kappa-
chain-enhancer of activated B cells (NF-ϰB) could not be successfully colonized, 
similarly this was found in a chicken. This study identified the importance of NF-ϰB to 
the functionality of CdtB (55). 
Adhesions 
 Surface adhesions or pili are used to successfully colonize a host cell (55). 
Campylobacter spp. do not have any known pili; however, they do have Type-II like 
secretions systems similar to Vibrio cholera, which allows for pilus assembly. In addition 
to a Type-II like secretion system, many adhesion proteins are also found, like CadF, 
JlpA, Cap A, Peb1, and Cj1496c (55). CadF is essential for binding and host cell 
invasion (55). JlpA and CapA are lipoproteins found within C. jejuni. JlpA creates the 
inflammatory responses experienced during campylobacteriosis and CapA acts as an 
autotransporter. In a chicken study, CapA was identified when mutant strains were not 
capable to adhere to cells, leading to a decrease in colonization and infection (55). 
Peb1 (CBF1), located in the periplasm, acts like an ATP-binding cassette transporter 
allowing high levels of aspartate and glutamate binding. In studies, peb1 mutant strains 
could not affectively grow and cause infection; however, it was unclear if poor infection 
  
 
23 
occurred due to the knockout of peb1, low amino acid levels, or both (55). The final 
adhesion has been identified as Cj1496c for effective host cell infection for C. jejuni 
infections specifically. Cj1496c is a periplasmic magnesium transporter protein and 
important to the strain’s ability to adhere to host cells. This is the only known 
mechanism (55). 
Lipopolysaccharides (LPS) 
 Lipopolysaccharides are found extensively on the surface of Gram-negative 
microorganisms. The LPS is made of 3-layers – Lipid A, core, O-antigen – which allow 
for adhesion and surface alteration to avoid host immune response (2, 55). It is believed 
that the LPS is the primary factor to GBS. Sialic acid and N-acetyl neuraminic acid are 
uncommon within prokaryotes. When sialic acid is paired to D-galatosidase, it appears 
to mimic a ganglioside or a molecule on the cell’s surface involved in host cell function 
and expressed in nervous tissues (2, 54). Previous studies identified GM1, a 
ganglioside, as having correlation to the presence of IgM antibodies; however, GM1 was 
not present within all GBS positive cases. When Yuki (56) studied GBS+/Cj+ (GBS 
positive/C. jejuni positive) patients and GBS-/Cj+ (GBS negative/C. jejuni positive) 
patients, he identified similar results. Yuki found GBS+/Cj+ cases with IgG anti-GM1 
antibodies and no anti-GM1 antibodies identified within GBS-/Cj+ cases (56). Yuki 
further extracted the LPS from GBS+/Cj+ collected samples for Penner’s 16 serotype 
(PEN 19). The LPS contained “galactose, N-acetylgalactosamine, and N-
acetylneuraminic acid,” which make up the composition of GM1 (56). This showed 
“molecular mimicry between nerve tissue and the infectious agent isolated from a GBS 
patient” (56). 
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Conclusion 
Since first being identified as a foodborne pathogen in the 1980s, there remains 
a lack of understanding as to where Campylobacter spp. are located within the natural 
environment given their fastidious nature. Even as our ability to detect this organism 
improves, cases of campylobacteriosis continue to be predominantly sporadic and 
underreported deterring from epidemiologic studies for source identification. 
Additionally, with increased surveillance and infections being increasingly identified via 
culture independent tests, antibiotic resistance knowledge is essential to understand 
treatment of campylobacteriosis in the future. Therefore, it is important to better 
understand the prevalence of Campylobacter spp. within the environment, mechanisms 
of adaptation, and the potential to contaminate vulnerable commodities such as 
produce, which have been linked but not traditionally focused on as vehicles for 
Campylobacter spp. infections. 
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Chapter II: Enumeration, Isolation, and Detection of Campylobacter 
species within the Environment of East Tennessee  
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Publication for the Journal of Food Protection 
Abstract 
Campylobacter species are among the main causes of bacterial gastroenteritis in 
the United States and commonly associated with the consumption of poultry, meat, and 
raw milk. East Tennessee counties experience a higher prevalence of 
campylobacteriosis compared to other regions of the state, based upon Tennessee 
Department of Health (TDH) surveillance. This study aimed to identify if Campylobacter 
spp. exist within food stuffs, animal feces, and river water from East Tennessee to 
better understand possible vehicles for campylobacteriosis within the region. From 
March through August 2017, samples (n=258) were collected from local farmers’ 
markets, parks, processing facilities, and rivers.  A food or fecal sample was diluted and 
incubated at 37˚C for 4 h then 44 h at 42˚C in a microaerophilic environment (5% O2, 
10% CO2, 85% N2). Water samples were vacuum filtered through a 0.45μm membrane 
filter. Samples were plated onto Campy CHROMagar® and incubated in a 
microaerophilic environment for 4 h at 37˚C then 44 h at 42˚C for isolation of 
Campylobacter. All presumptive positive samples (n=46) were confirmed via PCR with 
targets for Campylobacter spp., C. jejuni, C. coli, and C. lari. Forty-two samples were 
confirmed as Campylobacter spp. – microgreens (n=5/5; 100%), sprouts (n=2/3; 66%), 
Tennessee River water (n=8/8; 100%), Hiwassee River water (n=6/7; 86%), cattle feces 
(n=5/6; 86%), swine feces (n=12/13; 92%), and geese feces (n=4/4; 100%). Twelve 
pork fecal samples were confirmed as C. coli and one goose and one cattle fecal 
sample as C. jejuni. PCR confirmed isolates (n=39) were tested for antibiotic resistance. 
Twenty isolates (51%) expressed no growth and nineteen isolates (19%) were 
susceptible to antibiotics, 9 (23%) expressed intermediate growth, and eleven (28%) 
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expressed complete resistance to antibiotics within the screening assay, according to 
the Clinical and Laboratory Standards Institute (CLSI) guidelines. These data indicate 
that antibiotic resistant Campylobacter spp. are present in surface waters, animal feces, 
and sprouted seeds within East Tennessee and could result in negative implications for 
treatment and overall health complications for the region. 
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Introduction 
Overview 
 Campylobacter species (Campylobacter spp.) are microaerophilic, Gram-
negative, curved rods with a single, polar flagellum (12, 33). First identified as a cause 
of veterinary spontaneous abortions, Campylobacter spp. are naturally occurring 
microorganisms within the normal intestinal microflora of warm-blooded animals (1, 33). 
Campylobacteriosis is the diarrheal illness caused 24-48 hours following consumption, 
but this varies based on immune status, age, and number of pathogens consumed. A 
person might experience abdominal pain, cramps, diarrhea, malaise, headache, or fever 
for 2-7 days; however, one can shed the microorganism for months following the 
cessation of symptoms (12). Campylobacteriosis can lead to post-infection sequelae, 
including Guillain-Barré syndrome (GBS), reactive arthritis (ReA) or Reiter’s Syndrome, 
and irritable bowel syndrome (IBS). The 2016 Foodborne Disease Active Surveillance 
Network (FoodNet) progress report reported Campylobacter as having the highest 
incidence of confirmed cases at 11.79 cases per 100,000 with the majority (99%) of 
Campylobacter cases occurring sporadically with peaks during the warmer months of 
May-August (16, 34).   
Reservoirs 
 Originally classified as Vibrio species, there are 27 identified Campylobacter spp. 
and eight subspecies with Campylobacter jejuni (C. jejuni) serving as the species 
causing the greatest number of human campylobacteriosis cases (12, 15, 20). Since the 
surveillance of Campylobacter spp. began in 1982, Campylobacter spp. have been 
linked to outbreaks related to water and food (9, 11, 21, 29, 30, 33, 34). The Centers for 
Disease Control and Prevention (CDC) educates consumers on increased risks of 
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campylobacteriosis due to the consumption of raw or undercooked poultry, cross 
contamination with raw or undercooked poultry, raw dairy products, untreated water, 
and produce (6). In a 2002 review by Newell (19), Campylobacter spp. are considered 
commensals in birds and have the ability to colonize the gut of most mammals. Gut 
colonization, in birds, appears within 2-3 weeks after hatch and can be detected among 
entire flock within 3 days (19). Countries with poultry flock surveys report up to 95% of 
flocks test positive for Campylobacter spp. (19). 
Campylobacter and the Environment  
Following a three-year study of a southern Ontario, Canada watershed, 
thermophilic Campylobacter spp. were identified in 57-79% of the samples collected 
from five locations using quantitative PCR (37). Biweekly samples from five sites 
upstream from municipal drinking water treatment plants were collected by removing 
water 2-3 m from the river’s edge and 10-20 cm below the surface in fast flowing areas 
from 2005 through 2008. In 2007, waterfowl fecal samples were collected from areas 
near collection sites. Researchers isolated Campylobacter lari (66%), C. jejuni (30%), 
and C. coli (9%) from river water positive samples (37). C. jejuni (73%), C. lari (27%), 
and C. coli (13%) were isolated from waterfowl fecal samples (37). High quantities of 
nalidixic acid susceptible C. lari were identified among both river water and fecal 
waterfowl samples. Following 16S rRNA sequence, 100% homology was identified 
among a seagull fecal sample and a nearby collected water samples (37). Research 
from this study allows for a better understanding of surface and drinking water 
contamination in southern Ontario and how they may serve as modes of transmission 
for campylobacteriosis.  
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Campylobacter and Produce 
Campylobacter spp. are rarely identified as a biological hazard for fruits and 
vegetables. However, there have been well documented outbreaks associated with 
produce, demonstrating the ability of Campylobacter spp. to survive within this 
environment (4). In a recently completed meta-analysis of the prevalence of 
Campylobacter spp. in fresh fruits and vegetables, the prevalence of contamination was 
estimated to be 0.53% among fresh produce (17). Bean and sprouts were found to have 
the highest reported prevalence (11.08%) of fresh produce (17). 
Doyle and Schoeni (10) identified that while rare, fresh produce, specifically ones 
packaged in “polyvinyl chloride film-wrap” can serve as a vehicle for campylobacteriosis. 
C. jejuni contamination was identified within 1.5% (n=200) of retail mushrooms. Their 
hypothesis was the peat and lime casing material in addition to the moist growth 
environment aided in the survival of C. jejuni. These wrapped mushrooms, while held at 
refrigeration temperatures, are in a low oxygen environment, allowing for the survival of 
this microaerophilic pathogen (10).  
To better understand the Danish national incidence, researchers led a 
prospective case-control study from January to December of 2016 utilizing an online 
questionnaire, resulting in 887 cases and 2915 controls (13). Researchers aimed to 
determine sources including non-food items that place 1 to 30 year olds at risk for 
campylobacteriosis. Overall, traveling abroad was the main risk factor for 
campylobacteriosis (OR=4.6, 95% CI 3.7-5.7); however, there were many additional risk 
factors found to be statistically significant, including those who bathed in fresh water 
(OR=6.0, 95% CI 3.0-11.9) or those who consumed whole chicken (OR=2.2, 95% CI 
1.8-2.9), boneless chicken fillets (OR=2.1, 95% CI 1.6-2.6), or chicken thighs (OR=1.6, 
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95% CI 1.2-2.0) (13). Additional foods, such as fruits and vegetables were included for 
their association with campylobacteriosis. Campylobacteriosis was determined likely 
following the consumption of fresh strawberries (OR=1.6, 95% CI 1.3-2.1), fresh 
raspberries (OR=1.5, 95% CI 1.1-1.9), fresh blueberries (OR=1.2, 95% CI 1.1-1.8), and 
frozen berries (OR=1.3, 95% CI 1.0-1.8) (13). 
Antibiotic Resistance Amongst Campylobacter spp. 
Campylobacteriosis is a foodborne infection that is treated with fluids and oral 
antibiotics. Antibiotics are either bactericidal, those that kill the bacteria, or 
bacteriostatic, those that inhibit growth and allow for immune response for bacterial 
death. Additionally, antibiotics can be classified based upon their mechanism of action: 
inhibiting cell wall synthesis, protein synthesis, DNA synthesis, RNA synthesis, folate 
synthesis, or a combination. Penicillin and cephalosporin classes inhibit bacterial cell 
wall synthesis by inhibiting transpeptidase. Macrolides and tetracyclines are 
bacteriostatic, while aminoglycosides are bactericidal; however, these three classes all 
inhibit protein synthesis. Fluoro/quinolones block DNA synthesis by binding DNA gyrase 
(38). Campylobacteriosis is commonly treated using erythromycin (a macrolide), 
tetracycline, or ciprofloxacin (a fluoro/quinolone) (28). 
Since the development of the National Antimicrobial Resistance Monitoring 
System-Enteric Bacteria (NARMS) in 1996, the presence of antibiotic resistance within 
human isolates, retail meats, and animals slaughtered for food has been monitored (8). 
In 1999, Minnesota researchers investigated if there was a change in fluoro/quinolone- 
or nalidixic acid-resistance within Minnesota isolates from 1992 to 1998. Researchers 
found, among state isolates, resistance increased from 1.3% to 10.2% with the majority 
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of isolates being associated to international travel or taking preventative antibiotics while 
traveling or upon return (28).  
Notable Antibiotic Resistant Outbreaks 
 In recent years, there were two noteworthy Campylobacter outbreaks that 
revealed resistance to multiple antibiotics. Beginning in early August to October 2016, 
Colorado health officials identified a raw milk outbreak through a herd share program. 
Following interviews, twelve confirmed cases were found, ranging from 12-68 years in 
age, and resulted in one hospitalization and zero deaths. Cases ranged in age from 12-
68 years. Case isolates (n=10) and milk samples (n=4) were analyzed using pulse-field 
gel electrophoresis (PFGE) for C. jejuni. All case isolates and two milk isolates were 
confirmed for C. jejuni and expressed resistance to ciprofloxacin, tetracycline, and 
nalidixic acid, following NARMS testing (3).  
In 2017, a Campylobacter outbreak related to puppies at pet stores involved 18 
states and 118 cases. Based on case interviews, 105 cases reported a dog exposure 
with 95% reporting contact with a puppy at a pet store and eight reporting contact or 
purchasing a puppy from another pet store. This outbreak had 26 hospitalized cases 
and no deaths. Following a review of puppy records, puppies received prophylactic 
treatment (n=78), prophylactic and antibacterial treatment (n=54), or only antibacterial 
treatment (n=2). Of those antibiotics dispensed, broad-spectrum antibiotics, like 
doxycycline and azithromycin, accounted for 81%, in addition to sulfadimethoxine, a 
veterinary antibiotic. This brought attention to the use of antibiotic treatment within the 
commercial dog industry. Eighteen isolates were resistant to azithromycin, ciprofloxacin, 
clindamycin, erythromycin, nalidixic acid, telithromycin, and tetracycline with some 
samples resistant to gentamicin and florfenicol (18). Some of these antibiotics represent 
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the main treatment lines for campylobacteriosis patients, rendering these treatments as 
ineffective (7). 
 For this current study, researchers aimed to understand to what extent 
Campylobacter spp. are present within the East Tennessee waterways, foodstuffs and 
in fecal material of wild and domestic animals within this region.  Campylobacter 
isolates were speciated for C. coli, jejuni and lari to determine prevalence of the most 
commonly associated species for campylobacteriosis in addition to antibiotic resistance. 
 
Materials and Methods 
Microbiological Media 
Four types of media were utilized to aid in the identification, enumeration, and 
isolation of Campylobacter spp. from locally grown foods, fecal samples, and water 
samples collected throughout East Tennessee. 
Enumeration Broth 
Bolton Broth (BB) (Oxoid, Bashingstoke, Hampshire, England) was used for the 
enumeration of Campylobacter spp. from locally growth foods and fecal samples 
collected throughout East Tennessee. It was prepared by following the company’s 
instructions and was stored in sterilized glass bottles at refrigeration temperature until 
use. Upon use, broth bottles were brought to room temperature and enriched with 
Bolton Broth selective supplement (Oxoid, Bashingstoke, Hampshire, England) 
following manufacturer’s instructions.  
Enumeration Media 
CHROMagarTM Campylobacter (CHROMagarTM, Paris, France) was used for the 
selection and differentiation of Campylobacter species, by the presence of a red, pin-tip 
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colony on agar plates. CHROMagarTM Campylobacter allowed for the growth of 
Campylobacter jejuni, Campylobacter coli, and Campylobacter lari, which are most 
commonly linked to human illness. 
Isolation Media 
Mueller-Hinton (Oxoid, Basingstoke, Hamshire, England) was used as the media 
base for Mueller-Hinton Campylobacter blood plates for isolation. Manufacturer’s 
instructions were followed. Once cooled, the following antibiotic supplements were 
added the media: (1) 16.0 ppm cefoperzone (Tokyo Chemical Industry Co, Portland, 
OR); (2) 1.0 ppm trimethoprim (Tokyo Chemical Industry Co, Portland, OR); (3) 1.0 ppm 
vancomycin hydrochloride (Alfa Aesar, Ward Hill, MA); (4) 0.5 ppm cycloheximide (VWR 
Life Science, Solon, OH); (5) 10% (v/v) defibrinated sheep’s blood (HemoStat 
Laboratories, Dixon, CA). 
Freezer Stock 
Bolton broth (Oxoid, Basingstoke, Hampshire, England) made following 
manufacturer’s instructions and 50% glycerol (Fisher Scientific, Fair Lawn, New Jersey) 
was used to create a 1.5 mL freezer stock solution. Samples with characteristic 
Campylobacter spp. growth were frozen for future use. 
Sample Collection 
 Samples were obtained from eighteen counties within the greater East 
Tennessee geographical region. 
Food Stuffs 
Fresh dairy, meats, and produce were purchased from an area farmers’ market 
monthly. These samples included: cheese, eggs, carrots, cucurbits, microgreens, 
radishes, sprouts, tomatoes, tree fruits, mushrooms, poultry, and beef. Samples were 
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purchased during bi-weekly farmers’ market visits from June 2017 to August 2017 when 
available and transported back to the research facility for additional processing. 
Fecal Samples 
Samples of cattle, geese, and swine were collected from local parks and 
livestock processing facilities. At each site (n=7), a 36oz Whirl-Pak bag (Nasco, Fort 
Atkinson, WI) was filled halfway with feces. Bags were secured for aseptic transport 
back to the laboratory for further processing. Three samples were collected from each 
site monthly from March 2017 through July 2017. 
Water Samples 
At water sampling sites (Figure 2.1), a 36oz Whirl-Pak bag (Nasco, Fort 
Atkinson, WI) was connected to a 25-ft sampling line (Nasco, Fort Atkinson, WI) and 
thrown out into the water, skimming the surface as it was pulled back making sure to fill 
the bag three-fourths full. 
From each collected sample, the temperature was recorded, at the time of 
collection, using a calibrated Traceable Waterproof thermometer (Fisher Scientific, 
Pittsburgh, PA), followed by fastening the sample for aseptic transport to the laboratory 
site. Three samples were collected at each site during each sampling day. Monthly 
water sampling occurred for both sites from March 2017 to July 2017.  
Sample Processing 
Food and Fecal Sample Isolation 
A 25 g food or fecal sample was placed into a 36 oz Whirl-Pak bag (Nasco, Fort 
Atkinson, WI) along with 225 mL BB with supplements, made following manufacturer’s 
instructions. Samples were incubated for 4 h at 37°C in a HERAcell 150i tri-gas 
incubator (ThermoFisher, Pittsburg, PA) with 5% O2, 10% CO2, and 85% N2 (Airgas, 
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Knoxville, TN), then increased to 42°C for the remaining 44 h. Following incubation, 
using a 10 µL disposable inoculating loop/needle (ThermoFisher Scientific, Foster City, 
CA), samples were streaked for isolation onto CHROMagarTM Campylobacter base 
plates. Plates were inverted and incubated for 4 h at 37°C then 44 h at 42°C.  
Water Sample Isolation 
Using sterile forceps, a 47 mm, 0.45 µm sterile filter (PALL Life Sciences, Ann 
Arbor, MI) was placed onto a funnel base before volumes (10 mL or 100 mL) were 
pipetted using a 10 mL serological, sterile pipet (VWR, Atlanta, GA) or 100 mL 
serological, sterile pipet for filtration (CELLTREAT, Pepperell, MA), in duplicate. 
Following filtration, the filter was placed grid side up on CHROMagarTM Campylobacter 
base plates. Once all samples were processed, inverted plates were incubated as 
previously described. Plates with characteristic Campylobacter spp. growth according to 
CHROMagarTM interpretation guide (red, pin-tip colony) were categorized as 
presumptive positive. 
Sample Confirmation 
Isolation of Presumptive Campylobacter spp. 
One presumptive Campylobacter colony was removed from CHROMagarTM 
Campylobacter base plates using a 10 µL disposable inoculating loop/needle (Thermo 
Fisher Scientific, Foster City, CA) and streaked for isolation onto Mueller-Hinton blood 
plates and incubated at 42°C for 24 h with 5% O2, 10% CO2, and 85% N2.  
DNA Extraction using Boiling Lysis 
To prepare for DNA extraction, an isolated colony from Mueller-Hinton blood 
plates was removed using a 10 µL disposable inoculating loop/needle (Thermo Fisher 
Scientific, Foster City, CA) and transferred into 10 mL Buffered Peptone Water (BPW; 
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BD Difco, Sparks, MD) and incubated at 42°C for 24 h with 5% O2, 10% CO2, and 85% 
N2. Turbid tubes were removed, and 1.5 mL was transferred into an Eppendorf 
microcentrifuge tube (Eppendorf, Hauppauge, NY). Tubes were centrifuged at 10,000 x 
g for 5 minutes at 25°C using an AccuSpin Micro 17R microcentrifuge (Fisher Scientific, 
USA). Following centrifugation, the supernatant was discarded and 500 µL, 0.85% 
saline solution (Quality Biological, Gaithersburg, MD) was used to re-suspend the cell 
pellet then centrifuged at 10,000 x g for 3 minutes at 25°C. Again, the supernatant was 
discarded, and the pellet was re-suspended in 90 µL 1X Tris-EDTA (TE) buffer (Fisher, 
Fair Lawn, New Jersey). Cells were heated in a 97±2°C water bath for 15±1 minutes. 
Following heating, tubes were placed into refrigeration for 5 minutes then centrifuged a 
final time at 16,000 x g for 4 minutes at 25°C. Following centrifugation, without 
disturbing the pellet, the supernatant was transferred into a new, sterile microcentrifuge 
tube (Fisherbrand, Fair Lawn, New Jersey) and stored at -20°C until PCR analysis. 
PCR 
Four primer sets were used for PCR conformation to identify Campylobacter 
spp., C. jejuni, C. coli, and C. lari (Table 1), as described by Saiyudthong et al, 2015 
(26). For each 20 μL singleplex PCR reaction, the following was added to a sterile, 
Eppendorf microcentrifuge tube: 1.0 μM forward and reverse primers, 1 μL extracted 
DNA (with final concentrations ranging from 91-1265 ng/μL), 1X AmpliTaq Gold Fast 
PCR Mastermix (Applied Biosystems by ThermoFisher Scientific; Foster City, CA), and 
the remainder in nuclease free water (Fisher, Fair Lawn, NJ).  
PCR analysis which was conducted in a SimpliAmp Thermal Cycler (Thermo 
Fisher Scientific, Foster City, CA) with the following conditions: 35 cycles of 96°C for 3 
seconds, 62°C for 3 seconds, 68°C for 5 seconds; and a final elongation at 72°C for 10 
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minutes. Samples were held at 4°C until amplified products were visualized using gel 
electrophoresis. 
Gel Electrophoresis 
PCR products were examined for the presence of target sequences using an E-
Gel EX 1% Agarose gel (Thermo Fisher Scientific, Foster City, CA) and read by the 
Invitrogen gel reader (Thermo Fisher Scientific, Foster City, CA) using a 1 Kb DNA 
ladder for reference (Thermo Fisher Scientific, Foster City, CA) and 10 µL 1X E-Gel 
Sample Loading Buffer (Thermo Fisher Scientific, Foster City, CA). Electrophoresis was 
conducted for 10 min at 48 V, 90 W and examined for characteristic bands at 1062 bp 
(16S rDNA), 773 bp (random sequence), 502 bp (Aspartokinase gene), or 251 bp (glyA 
gene) for Campylobacter spp., C. jejuni, C. coli, and C. lari identification, respectively 
(26). 
Presence of Campylobacter spp. 
Following gel electrophoresis, samples that were confirmed as positive for the 
presence of Campylobacter spp. or one of the species-specific targets were identified. 
These samples were further analyzed to determine antibiotic resistance and to better 
understand the prevalence of antibiotic resistance within regional animals, food, and 
water. 
Antimicrobial Testing of Confirmed Campylobacter spp. 
Frozen sample cultures were streaked onto 5% TSA (BD Difco, Sparks, MD) with 
sheep’s blood (HemoStat Laboratories, Dixon, CA) for isolation and incubated at 36°C 
for 24 h with 5% O2, 10% CO2, and 85% N2. Following incubation, plates were swabbed 
using a sterile cotton swab (Puritan, Guilford, ME) and placed into 5mL Sensititre cation 
adjusted Mueller-Hinton broth tubes with TES buffer (CAMHBT) (Thermo Scientific, 
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Lenexa, KS). Each tubes was vortexed well and 100 µL were transferred into Sensititre 
CAMHBT + lysed horse blood (LBH) (Thermo Scientific, Lenexa, KS). Once vortexed, 
the tube was emptied into a sterile well basin and 100 µL were pipetted into each well of 
the CAMPY2 Sensititre plate (Thermo Scientific, West Sussex, UK). Plates were 
covered with a perforated adhesive seal, avoiding creases and making sure to place 
perforation over the well. Plates were incubated at 42°C for 24 h with 5% O2, 10% CO2, 
and 85% N2. All plates were incubated within 30 minutes of starting the experiment and 
staked three high to maintain desired atmosphere and temperature. Plates were 
interpreted following incubation for turbidity or aggregation of cells at the bottom of the 
well.     
 
Results and Discussion 
Collection and Detection of Campylobacter spp.  
During this preliminary study, samples (n=258) were collected from farmers’ 
markets, livestock processing facilities, public parks, and surface river water (Figure 
2.2). Results indicated presumptive presence of Campylobacter spp. in 47 (18%) 
samples and confirmed Campylobacter spp. presence in 43 (91%) of those samples. C. 
coli was isolated in twelve samples (28%) and C. jejuni in two (5%). C. lari was not 
isolated. The remaining 67% of isolates did not belong to one of these three species.   
Over the five months, Campylobacter were isolated from surface river water 
(n=14, 67%), microgreens (n=5, 56%), swine feces (n=13, 54%), cattle feces (n=5, 
21%), geese feces (n=4, 12%), sprouts (n=2, 8%). Campylobacter spp. were not 
isolated from tomatoes (n=24), cucurbits (n=21), beef cuts (n=18), poultry cuts (n=15), 
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eggs (n=12), tree fruits (n=12), raw cheese (n=6), raw milk (n=6), carrots (n=3), 
radishes (n=3), or mushrooms (n=3).  
Campylobacter are traditionally linked to the consumption of raw and 
undercooked poultry and raw milk; however, this study shows that Campylobacter spp. 
isolation can be challenging and there might be additional environmental sources which 
may act as vehicles for human disease. After studying Canadian watersheds for three 
years, Van Dyke et al (37) detected C. lari in seagulls, ducks, and geese (32%) 
following PCR explaining the presence of Campylobacter within watersheds. Similarly, 
researchers at North Carolina State University identified C. jejuni (n=26) among urban 
Canadian geese samples (n=218) collected over a two-year period, of which all isolates 
were susceptible to six tested antibiotics (25). This brings attention to a need at the 
regional or community-level for environmental assessments for additional 
campylobacteriosis risks.  
In addition to animals for food and waterfowl being found to carry Campylobacter 
spp., this current study identified fresh produce also carrying Campylobacter spp. As 
previously mentioned, less than 1% of produce overall was estimated to be 
contaminated with bean and sprouts having the highest reported prevalence (11.08%) 
among fresh produce (17). In this current study, microgreens (56%) and sprouts (8%) 
were found to be contaminated, while other produce, including tomatoes, cucurbits, tree 
fruits, carrots, radishes, and mushrooms showed no detectable growth of 
Campylobacter spp. These data were unlike the research by Doyle and Schoeni (10). 
Antibiotic Resistance 
 PCR confirmed isolates (n=39) were tested for antibiotic resistance according the 
CLSI guidelines adhering to the NARMS categorization of antibiotic resistance within 
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the 2010 NARMS Executive Summary (Table 2.3 and Table 2.4) (35). Twenty isolates 
(51%) did not exhibit any growth at the lowest concentrations of all antibiotics evaluated. 
Of the remaining 19 isolates, all showed susceptibility to at least one antibiotic 
evaluated (Tables 2.3 and 2.4) (24).  
 Eleven isolates (28%) expressed antibiotic resistance, which is defined as an 
inability to successfully inhibit bacterial growth in vitro following a proper therapeutic 
dosage (Tables 3 and 4) (24). Of these isolates, four (36%) were resistant to one 
antibiotic.  These isolates were obtained from microgreens, river water from Site E, and 
swine feces. Three isolates (27%) were resistant to two antibiotics and were obtained 
from water at Sites C and E and cattle feces. Four isolates obtained from geese and 
swine feces were resistant to three or more antibiotics.  One swine fecal isolate (9%) 
was resistant to three antibiotics. Two goose fecal samples showed resistance to five 
and six antibiotics, respectively, and a swine fecal sample isolate was resistant to seven 
antibiotics. No isolate expressed resistance to all eight antibiotics tested.  
Amongst isolates obtained in this study, the greatest resistance was seen in 
nalidixic acid, a quinolone, with 18% of all isolates showing resistance (Table 2.4).  
Clindamycin and tetracycline resistance were observed in 15% of isolates. Macrolide 
antibiotics are most commonly prescribed for treating campylobacteriosis (6).  Three 
and eight percent of isolates obtained in this study were resistant to azithromycin and 
erythromycin, respectively, and were isolated from geese and swine feces (Table 2.4). 
Erythromycin resistance reported amongst C. coli and jejuni isolates analyzed through 
the National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), 
has remained below 4% for human and poultry isolates, but 13% of swine fecal samples 
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were exhibited resistance in 2015 (36). Ciprofloxacin can also be used to treat 
campylobacteriosis (6). Ciprofloxacin resistance from NARMS isolates have ranged 
from 0% in sows and turkeys to 10.4% in chicken and up to 50% in chicken (36). Only 
5% of isolates in this study were resistant to ciprofloxacin and gentamicin, respectively. 
Only one isolate obtained from geese feces expressed resistance to all three antibiotics 
commonly prescribed for treatment.  
Other studies have found the highest resistance to azithromycin amongst isolates 
obtained from children and poultry (n=147) (31). Conversely, only one isolate was 
resistant to this antimicrobial at therapeutic levels in this study (Table 2.3 and 2.4). 
Based upon these data, main treatment lines (erythromycin and ciprofloxacin) remain 
an option for more severe campylobacteriosis cases, which the CDC states resistance 
to azithromycin would be a serious public health threat (5). 
Fluoro/quinolone resistance was detected in a 2016 outbreak related to raw milk 
consumption in Colorado. Five of the ten confirmed case isolates were confirmed for 
resistance to ciprofloxacin, tetracycline, and nalidixic acid with two of these being a 
main treatment line for campylobacteriosis (3). As previously mentioned, the 2016-2018 
puppy store outbreak contained eighteen isolates susceptible to seven antibiotics: 
azithromycin, ciprofloxacin, clindamycin, erythromycin, nalidixic acid, telithromycin, and 
tetracycline (18). Bolinger and Kathariou revealed macrolide (azithromycin and 
erythromycin) resistance among C. coli isolates; this trend was only seen among one C. 
coli isolate obtained from swine feces which was resistant to erythromycin (2). 
Additionally, researchers found pond isolates (85%) to be resistant to ciprofloxacin 
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unlike this preliminary study, which no river water (n=14) expressed resistance to 
ciprofloxacin (31). 
While the current study did not evaluate human isolates, there are 
Campylobacter species known to harbor the human oral cavity, such as C. concisus, C. 
carvus, C. showae, C. rectus, and C. gracilis (20, 32) which has led to discussions on 
non-C. jejuni infections. Campylobacteriosis is a leading cause of pathogenic diarrhea 
among children under 2 years of age and can lead to weight loss and hindered height 
growth among children 2 to 5 years old (14, 15, 22, 23, 27). In a cohort of children, 
Schiaffino et al, (27) speciated 917 cultures of which 596 (65%) were C. jejuni isolates 
and 321 (35%) were non-C. jejuni. Of the non-C. jejuni isolates, 15.8% were resistant to 
gentamycin, while this current study identified 5% (27). Additionally, multi-drug resistant 
(MDR) isolates accounted for 59.1% and this current study identified 54% (n=6) MDR 
isolates (27). 
 As campylobacteriosis continues to be a leading bacterial foodborne illness, it is 
imperative that researchers have a better understanding of the number of sporadic 
cases. This study demonstrates the environmental reservoirs and the foodstuffs from 
which Campylobacter spp. can be isolated and exposures may occur at parks, rivers, 
and in locally grown food commodities. With the sporadic nature of campylobacteriosis, 
it is hard to understand what role non-Campylobacter jejuni and coli isolates may play 
with respect to human illness. Even self-limiting diarrheal illnesses negatively impact 
productivity. Isolates obtained in this study should be further characterized to better 
understand what pathogenicity elements they have in addition to the currently 
characterized antimicrobial resistance. Additionally, this study emphasizes the 
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importance of antimicrobial stewardship as campylobacteriosis continues to be a 
leading bacterial foodborne illness. Campylobacter spp. have shown capability of 
developing antibiotic resistance. The loss of effective antibiotic treatment would be 
detrimental to public health.  
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Chapter III:  Enumeration, Isolation, and Detection of Campylobacter 
species within the Tennessee River throughout the Greater Knoxville 
Area  
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Publication for the Journal of Water and Health 
Abstract 
Campylobacter spp. are one of the main causes of bacterial gastroenteritis in the 
United States. Campylobacteriosis is commonly associated with the consumption of 
poultry, meat, and raw milk; however, following a preliminary study, researchers 
quantified populations of Campylobacter spp. within the Tennessee River near 
Knoxville, TN. This study aimed to better understand the spatiotemporal distribution of 
Campylobacter spp. and further elucidate surface water as a possible vehicle for 
campylobacteriosis by sampling four sites (A-D) of the Tennessee River. Samples 
(n=264) were collected from four public access river sites for one calendar year 
(November 2017-November 2018). Samples were vacuum filtered through a 0.45μm 
membrane filter and plated onto Campy CHROMagar®. Plates were incubated in a 
microaerophilic environment (5% O2, 10% CO2, 85% N2) for 4 h at 37˚C then 44 h at 
42˚C for isolation of Campylobacter. Presumptive positives (n=244) were confirmed via 
PCR with targets for Campylobacter spp., C. jejuni, C. coli, and C. lari. Confirmed 
isolates were identified as Campylobacter spp. (n=168) and C. coli (n=5). All collection 
sites had a relatively high of Campylobacter spp. isolated [site A (n=30/38; 79%), site B 
(n=29/38; 76%), site C (n=77/132; 58%), and site D (n=32/36; 89%)]. Five water 
samples were confirmed as C. coli from site D, which were obtained from January to 
March. PCR confirmed samples (n=161) were tested for antibiotic resistance amongst a 
panel of eight antibiotics. Ninety-five (59%) isolates expressed resistance, of which 23 
(14%) isolates were resistant to one antibiotic, 27 (17%) isolates were resistant to two, 
18 (11%) were resistant to three, 12 (7%) were resistant to four, three (2%) were 
resistant to five, four (2%) were resistant to six, and five (3%) were resistant to seven, 
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and three (2%) were resistant to all eight. These data indicate that antibiotic resistant 
Campylobacter spp. are present within the surface waters of the Tennessee River 
throughout the Knoxville area.  This study shows a need to update campylobacteriosis 
risk factors, campylobacteriosis prevention education, and future treatment options. 
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Introduction 
Overview 
 Campylobacter species (Campylobacter spp.) are microaerophilic, Gram-
negative, curved rods with a single, polar flagellum (13, 38). Originally recognized as 
the cause of veterinary spontaneous abortions, Campylobacter spp. are commensals 
within the intestinal track of warm-blooded animals (2, 38). In 1978, Bennington, 
Vermont experienced the first known Campylobacter outbreak related to the 
contamination of the city’s municipal water supply (41). Campylobacteriosis is a 
gastrointestinal infection occurring 24-48 hours after consumption. Symptoms include 
abdominal pain, cramps, diarrhea, malaise, headaches, or a fever. These symptoms 
usually abate 2-7 days, depending on one’s immune state, age, and number of 
Campylobacter consumed. The microorganism can be shed for months following the 
cessation of symptoms (13). Campylobacteriosis can lead to post-infection sequelae, 
including Guillain-Barré syndrome (GBS), reactive arthritis (ReA) or Reiter’s Syndrome, 
and irritable bowel syndrome (IBS). FoodNet reported in 2016 that Campylobacter had 
the highest incidence of foodborne infections with 11.79 confirmed cases per 100,000 
persons; 99% of cases occur sporadically with peaks from May-August (18, 40).  
Reservoirs 
First classified as Vibrio, now there are 27 known species of Campylobacter and 
eight subspecies, with Campylobacter jejuni (C. jejuni) causing the greatest number of 
human campylobacteriosis cases (13, 17, 22). The Centers for Disease Control and 
Prevention (CDC) began active surveillance for Campylobacter spp. in 1982, and since 
campylobacteriosis outbreaks have been linked to water and food (10, 11, 24, 35, 36, 
38, 40). Currently, the CDC recognizes raw or undercooked poultry, cross 
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contamination with raw or undercooked poultry, raw dairy products, untreated water, 
and produce as risk for campylobacteriosis (6).  Given that Campylobacter spp. are 
commensals within warm-blooded animals, colonization of the gut can occur in birds 
within 2-3 weeks following hatching, and an infection can spread throughout an entire 
flock in 3 days (21). Poultry flock surveys report that 95% of flocks are positive for 
Campylobacter spp. (21). 
Campylobacter and Water 
 As mentioned earlier, the first known Campylobacter outbreak in the United 
States occurred in Bennington, VT in 1978 due to a system breach and a lack of free 
chlorine levels within a city’s municipal water supply (41). In 1983, staff and students 
(n=257) at a boarding school near Essex, United Kingdom experienced signs of 
gastroenteritis. Survey results identified an association with consumption of water from 
the school among staff (54%, p < 0.01) and students (11%, p < 0.01). Isolates (n=10) 
were sent for additional testing where six samples identified to have a common serotype 
and two strains were similar to those found in collected water samples from the school 
water supply (23). Similar to these outbreaks, researchers noticed high levels of 
gastroenteritis among wilderness hikers in the Grand Teton National Park in Jenny 
Lake, Wyoming during the summers of 1980 and 1981. C. jejuni was identified in 23% 
of hikers with gastroenteritis one week following the consumption of untreated surface 
water (39). To date, the largest United States waterborne Campylobacter outbreak 
occurred in 1999 in Washington County, New York. This outbreak resulted in over 116 
Escherichia coli O157:H7 infections and 13 co-infections with C. jejuni (5). Following a 
case-control study, public health officials identified 26/32 (81%) cases and 9/57 (16%) 
controls consumed water during the days in question; therefore, officials concluded that 
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“drinking water or beverages made with water from the suspect well was associated 
with illness” (5). Similar outbreaks have been experienced in Canada, New Zealand, 
and Scotland.  
In 1985, southern Ontario experienced an outbreak of 241 gastroenteritis cases 
from March 29-April 17. This resulted in 57 confirmed C. jejuni cases, and the outbreak 
investigation did not reveal any age or gender specific patterns. Following a case-
control study, those who consumed more glasses of water per day were more likely to 
have become ill (avg 4.6 glasses for cases vs avg 3.4 glasses for control) (19). While 
the epidemic curve displayed a common source outbreak, routine well water testing 
identified pathogenic contamination even though contamination was not expected, since 
this outbreak occurred in the springtime as ground snow was melting and few farm 
animals from wading. This outbreak brings light to Campylobacter spp. ability to survive 
in low ambient temperatures (19). A second waterborne Canadian outbreak occurred in 
2000 in Walkerton, Ontario. It was hypothesized that the Walkerton municipal water 
supply was contaminated via area farms following heavy rains, which allowed manure to 
enter the groundwater supply. Following testing of area farms, isolates expressed 
similar C. jejuni and C. coli strains to those linked to outbreak isolates (9). 
The first known New Zealand waterborne Campylobacter outbreak occurred in 
1990 outside Christchruch at a camp and conference center where two reports of C. 
jejuni were identified (37). Following interviews (n=99) of all camp leaders, staff, family, 
and campers, 44 cases were identified with 11 cases (25%) matching the case 
definition, 14 (32%) due to diarrhea history, and 19 (43%) due to expression of four or 
more symptoms (37). A case-control study was conducted which identified consumption 
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of ≥ 2 cups of non-boiled water a day (37). A second New Zealand outbreak occurred in 
Darfield, a rural community, in 2012. This outbreak resulted in 29 cases due to 
contaminated ground water supply due to nearby animal feces following heavy rains. 
While New Zealand had water regulations and standards at the time of this outbreak, it 
was not required for all water supplies, such as the one in Darfield (1). A third and 
largest documented outbreak occurred in Hastings, New Zealand in 2016 when one-
third of 14,000 residents were diagnosed with campylobacteriosis, in which three 
individuals died, and one person was diagnosed with Guillain-Barré (27, 28). This 
outbreak was recognized at the same time a positive groundwater test was identified. 
The New Zealand government implemented chlorination of groundwater supplies and 
put a water boil advisory into effect (27). It is believed that sheep feces was likely the 
cause of contamination (28). 
As a final example, a waterborne outbreak of Campylobacter occurred in 1995 in 
Fife, Scotland when 711 of the 1100 residents reported gastroenteritis resulting in 633 
cases (14). Of the cases, 70 stool samples were tested and resulted in the following 
identification – Campylobacter spp. (n=9), Rotavirus (n=1), and Escherichia coli O157 
(n=6) (14). While the village followed Scotland’s Water Supply Regulations of 1990, 
backflow from a local produce processor had contaminated the village’s water (14). 
These outbreaks demonstrate the ability of water to act as a reservoir for 
Campylobacter spp., especially when influenced by runoff from animal feces. 
Furthermore, these outbreaks elucidate the importance of water standards and multi-
barrier approaches, as well as routine testing of potable water for the prevention of 
pathogenic waterborne outbreaks. 
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Antibiotic Overview 
Campylobacteriosis is commonly treated with oral antibiotics and fluids. 
Antibiotics are bactericidal, those that kill bacteria, or bacteriostatic, those that inhibit 
growth and allow for immune response for bacterial death. Antibiotics are further 
classified based upon their mechanism of action: inhibition of cell wall synthesis, protein 
synthesis, DNA synthesis, RNA synthesis, folate synthesis, or a combination. Penicillin 
and cephalosporin classes inhibit bacterial cell wall synthesis by inhibiting 
transpeptidase. Macrolides and tetracyclines are bacteriostatic, while aminoglycosides 
are bactericidal; however, these three classes all inhibit protein synthesis. 
Fluoro/quinolones block DNA synthesis by binding DNA gyrase (45). With over 20 
classes of antibiotics, campylobacteriosis is commonly treated using erythromycin (a 
macrolide), tetracycline, or ciprofloxacin (a fluoro/quinolone) (34).  
The National Antimicrobial Resistance Monitoring System for Enteric Bacteria 
(NARMS) was established in 1996 in order to monitor antibiotic resistance within human 
isolates, retail meats, and animals for food (8). Since testing began in 1996, NARMS 
reports indicate erythromycin resistance is under 4% among human and chicken for C. 
jejuni isolates. This has remained true for C. jejuni isolates in the 2015 NARMS 
Integrated Report (43). However, erythromycin resistance among human, chicken, and 
retail chicken C. coli isolates has increased since 2011 from 2.7% (humans), 3.4% 
(chicken), 5.2% (retail chicken) to 12.7% (humans), 12.8% (chicken), and 12.7% (retail 
chicken) (43). 
Notable Antibiotic Resistant Outbreaks 
In recent years, there were two noteworthy Campylobacter outbreaks that 
revealed resistance to multiple antibiotics. Beginning in early August to October 2016, 
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Colorado health officials identified a raw milk C. jejuni outbreak through a herd share 
program. Following interviews, twelve confirmed cases were found, ranging from 12-68 
years in age, and resulted in one hospitalization and zero deaths. Cases ranged in age 
from 12-68 years. Case isolates (n=10) and milk samples (n=2) were linked for Sma 
enzyme following pulse-field gel electrophoresis (PFGE) analysis for C. jejuni.  All 
isolates that were screened expressed resistant to ciprofloxacin, tetracycline, and 
nalidixic acid (4). 
In 2017, a Campylobacter outbreak related to puppies at pet stores involved 118 
cases across 18 states. One hundred five cases reported a dog exposure, with 95% 
reporting contact with a puppy at a pet store, and eight reporting contact or purchasing 
a puppy from another pet store. This outbreak had 26 hospitalized cases. Following a 
review of puppy records, puppies received prophylactic treatment (n=78), prophylactic 
and antibacterial treatment (n=54), or only antibacterial treatment (n=2) of at least one 
antibiotic. Of those antibiotics dispensed, broad-spectrum antibiotics, like doxycycline 
and azithromycin, accounted for 81%, in addition to sulfadimethoxine, a veterinary 
antibiotic. This brought attention to the use of antibiotic treatment within the commercial 
dog industry. Eighteen isolates were resistant to azithromycin, ciprofloxacin, 
clindamycin, erythromycin, nalidixic acid, telithromycin, and tetracycline with some 
samples resistant to gentamicin and florfenicol (20). Azithromycin and ciprofloxacin are 
main treatment lines for campylobacteriosis patients (7). 
 For this current study, researchers aimed to understand to what extent 
Campylobacter spp. are present within the Tennessee River within Blount and Knox 
counties in Tennessee. Campylobacter were speciated for C. coli, jejuni, and lari to 
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determine prevalence of the most commonly associated species for campylobacteriosis 
in addition to antibiotic resistance. 
 
Materials and Methods 
Microbiological Media 
Three types of media were utilized to aid in the identification, enumeration, and 
isolation of Campylobacter spp. from water samples collected. 
Enumeration Media 
CHROMagarTM Campylobacter (CHROMagarTM, Paris, France) was used for the 
selection and differentiation of Campylobacter species, by the presence of a red, pin-tip 
colony on agar plates. CHROMagarTM Campylobacter allowed for the growth of 
Campylobacter jejuni, Campylobacter coli, and Campylobacter lari, which are most 
commonly linked to human illness. 
Isolation Media 
Mueller-Hinton (Oxoid, Basingstoke, Hamshire, England) was used as the media 
base for Mueller-Hinton Campylobacter blood plates for isolation. Manufacturer’s 
instructions were followed. Once cooled, the following antibiotic supplements were 
added the media: (1) 16.0 ppm cefoperzone (Tokyo Chemical Industry Co, Portland, 
OR); (2) 1.0 ppm trimethoprim (Tokyo Chemical Industry Co, Portland, OR); (3) 1.0 ppm 
vancomycin hydrochloride (Alfa Aesar, Ward Hill, MA); (4) 0.5 ppm cycloheximide (VWR 
Life Science, Solon, OH); (5) 10% (v/v) defibrinated sheep’s blood (HemoStat 
Laboratories, Dixon, CA). 
Freezer Stock 
Muller-Hinton broth (Oxoid, Basingstoke, Hampshire, England) made following 
manufacturer’s instructions and 50% glycerol (Fisher Scientific, Fair Lawn, New Jersey) 
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was used to create a 1.5 mL freezer stock solution. Samples with characteristic 
Campylobacter spp. growth were frozen for future use. 
Sample Collection 
Water Samples 
At each sampling site [A, B, C, and D (Figure 3.1)], a 36oz Whirl-Pak bag 
(Nasco, Fort Atkinson, WI) was connected to a 25-ft sampling line (Nasco, Fort 
Atkinson, WI) and thrown out into the water, skimming the surface as it was pulled back 
making sure to fill the bag three-fourths full.  
From each collected sample, the temperature was recorded, at the time of 
collection, using a calibrated Traceable Waterproof thermometer (Fisher Scientific, 
Pittsburgh, PA), followed by fastening the sample for aseptic transport to the laboratory. 
Three samples were collected at each site during each sampling day. Targeted weekly 
sampling occurred for Site C from November 2017 to November 2018, encompassing 
an entire year. Beginning in late-July 2018, sites A, B, and D were added to weekly 
collection until the end of November 2018. 
Sample Processing 
Direction Enumeration 
Using sterile forceps, a 47 mm, 0.45 µm sterile filter (PALL Life Sciences, Ann 
Arbor, MI) was placed onto a funnel base before volumes (10 mL or 100 mL) were 
pipetted using a 10 mL serological, sterile pipet (VWR, Atlanta, GA) or 100 mL 
serological, sterile pipet for filtration (CELLTREAT, Pepperell, MA), in duplicate. 
Following filtration, the filter was placed grid side up on CHROMagarTM Campylobacter 
base plates. Once all samples were processed, inverted plates were incubated for 4 h 
at 37°C in a HERAcell 150i tri-gas incubator (ThermoFisher, Pittsburg, PA) with 5% O2, 
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10% CO2, and 85% N2 (Airgas, Knoxville, TN), then increased to 42°C for the remaining 
44 h. Plates with characteristic Campylobacter spp. growth according to CHROMagarTM 
interpretation guide (red, pin-tip colony) were enumerated to indicate the number of 
presumptive Campylobacter spp. present for each collection site. For any sample, which 
at the lowest volume of water (10 mL or 100 mL) had greater than 250 colonies, but had 
5-10 colonies per square, 10 random squares were counted, added together, divided by 
10, then multiplied by 80 (filter area) to estimate Campylobacter population.  
Sample Confirmation 
Isolation of Presumptive Campylobacter spp. 
A presumptive Campylobacter colony was removed from CHROMagarTM 
Campylobacter base plates using a 10 µL disposable inoculating loop/needle (Thermo 
Fisher Scientific, Foster City, CA) and streaked for isolation onto Mueller-Hinton blood 
plates and incubated at 42°C for 24 h with 5% O2, 10% CO2, and 85% N2. 
DNA Extraction using Boiling Lysis 
To prepare for DNA extraction, an isolated colony from Mueller-Hinton blood 
plates was removed using a 10 µL disposable inoculating loop/needle (Thermo Fisher 
Scientific, Foster City, CA) and transferred into 10 mL Buffered Peptone Water (BPW; 
BD Difco, Sparks, MD) and incubated at 42°C for 24 h with 5% O2, 10% CO2, and 85% 
N2. Turbid tubes were removed, and 1.5 mL was transferred into an Eppendorf 
microcentrifuge tube (Eppendorf, Hauppauge, NY). Tubes were centrifuged at 10,000 x 
g for 5 minutes at 25°C using an AccuSpin Micro 17R microcentrifuge (Fisher Scientific, 
USA). Following centrifugation, the supernatant was discarded and 500 µL, 0.85% 
saline solution (Quality Biological, Gaithersburg, MD) was used to re-suspend the cell 
pellet then centrifuged at 10,000 x g for 3 minutes at 25°C. Again, the supernatant was 
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discarded, and the pellet was re-suspended in 90 µL 1X Tris-EDTA (TE) buffer (Fisher, 
Fair Lawn, New Jersey). Cells were heated in a 97±2°C water bath for 15±1 minutes. 
Following heating, tubes were placed into refrigeration for 5 minutes then centrifuged a 
final time at 16,000 x g for 4 minutes at 25°C. Following centrifugation, without 
disturbing the pellet, the supernatant was transferred into a new, sterile microcentrifuge 
tube (Fisherbrand, Fair Lawn, New Jersey) and stored at -20°C until PCR analysis. 
PCR 
As described by Saiyudthong et al, 2015, four primer sets were used for PCR 
conformation to identify Campylobacter spp., C. jejuni, C. coli, and C. lari (Table 3.1) 
(31). For each 20 μL singleplex PCR reaction, the following was added to a sterile, 
Eppendorf microcentrifuge tube: 1.0 μM forward and reverse primers, 1 μL extracted 
DNA (with final concentrations ranging from 91-1265 ng/μL), 1X AmpliTaq Gold Fast 
PCR Mastermix (Applied Biosystems by ThermoFisher Scientific; Foster City, CA), and 
the remainder in nuclease free water (Fisher, Fair Lawn, NJ).  
PCR analysis was conducted in a SimpliAmp Thermal Cycler (Thermo Fisher 
Scientific, Foster City, CA) using the following conditions: 35 cycles of 96°C for 3 
seconds, 62°C for 3 seconds, 68°C for 5 seconds; and a final elongation at 72°C for 10 
minutes. Samples were held at 4°C until amplified products were visualized using gel 
electrophoresis. 
Gel Electrophoresis 
PCR products were examined for the presence of target sequences using an E-
Gel EX 1% Agarose gel (Thermo Fisher Scientific, Foster City, CA) and read by the 
Invitrogen gel reader (Thermo Fisher Scientific, Foster City, CA) using a 1 Kb DNA 
ladder for reference (Thermo Fisher Scientific, Foster City, CA) and 10 µL 1X E-Gel 
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Sample Loading Buffer (Thermo Fisher Scientific, Foster City, CA). Electrophoresis was 
conducted for 10 min at 48 V, 90 W and examined for characteristic bands at 1062 bp 
(16S rDNA), 773 bp (random sequence), 502 bp (Aspartokinase gene), or 251 bp (glyA 
gene) for Campylobacter spp., C. jejuni, C. coli, and C. lari identification, respectively 
(31). 
Presence of Campylobacter spp. 
Following gel electrophoresis, samples that were confirmed as positive for the 
presence of Campylobacter spp. or for one of the species-specific targets were 
identified. These samples were further analyzed to determine antibiotic resistance and 
to better understand the prevalence of antibiotic resistance on a temporal and spacial 
basis. 
Antimicrobial Testing of Confirmed Campylobacter spp. 
Frozen sample cultures were streaked onto 5% TSA (BD Difco, Sparks, MD) with 
sheep’s blood (HemoStat Laboratories, Dixon, CA) for isolation and incubated at 36°C 
for 24 h with 5% O2, 10% CO2, and 85% N2. Following incubation, plates were swabbed 
using a sterile cotton swab (Puritan, Guilford, ME) and placed into 5mL Sensititre cation 
adjusted Mueller-Hinton broth tubes with TES buffer (CAMHBT) (Thermo Scientific, 
Lenexa, KS). Each tube was vortexed well and 100 µL were transferred into Sensititre 
CAMHBT + lysed horse blood (LBH) (Thermo Scientific, Lenexa, KS). Once vortexed, 
the tube was emptied into a sterile well basin and 100 µL were pipetted into each well of 
the CAMPY2 Sensititre plate (Thermo Scientific, West Sussex, UK). Plates were 
covered with a perforated adhesive seal, avoiding creases and making sure to place 
perforation over the well. Plates were incubated at 42°C for 24 h with 5% O2, 10% CO2, 
and 85% N2. All plates were incubated within 30 minutes of starting the experiment and 
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staked three high to maintain desired atmosphere and temperature. Plates were 
interpreted following incubation for turbidity or aggregation of cells at the bottom of the 
well.     
 
Results and Discussion 
Collection and Detection of Campylobacter spp. 
 Sample collection began in November 2017 for Site C resulting in 147 collected 
samples of which 75 were confirmed utilizing PCR as Campylobacter spp. (n=70) and 
C. coli (n=5). Sites A, B, and D began collection in July 2018 and resulted in 320 
samples. Following PCR confirmation, Sites A, B, and D consisted of only 
Campylobacter spp. (n=30, 32, and 29 respectively). Data show that even as water 
temperatures drop throughout the winter, Campylobacter are still present (6.1°C-
32.4°C). In SAS, a mixed models linear regression and post hoc for means separation 
was used to identify if a statistically significant difference (p<0.05) existed between 
months (November 2017 to November 2018). There is a statically significant difference 
(p=0.0229) among mean log counts/100 μL by month at site C (Figure 3.2). Additionally, 
when looking at a means separation among all collection sites (A, B, C, and D) for five 
months (July 2017 to November 2017). There is a statistically significant difference 
(p=0.0021) among mean log counts/100 μL for July 2017 to September 2017 as 
compared to the average counts from October 2017 and November 2017 (Figure 3.3). 
Research by Korhonen and Martikainen (15) found that C. jejuni survive better at 4°C 
than 25°C, could explain high levels of Campylobacter spp. during winter months. 
Additionally, the 1985 Ontario outbreak identified the capability of Campylobacter spp. 
to survive at lower temperatures than previously believed (19). In Finland, Schönberg-
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Norio et al (33) performed a matched case-control study (n=237) that identified three 
independent risk factors of campylobacteriosis: 1) tasting or eating raw or undercooked 
meat (OR 10.76, 95% CI 1.31-89.09); 2) drinking water from a dug well (OR 3.36, 95% 
CI 1.37-8.24); and 3) swimming in water from natural sources (OR 2.80, 95% CI 1.23-
6.39) all at p < 0.05. This study helps to substantiate the exposure to river water as a 
cause of sporadic campylobacteriosis. 
 This study identified non-C. jejuni and non-C. coli isolates among the Tennessee 
River watershed (Table 3.3). Similarly, Finnish researchers identified C. lari and 
unidentified Campylobacter spp. among bathing and purified sewage water samples in 
addition to C. coli and C. jejuni. It was noted that Campylobacter spp. samples were 
significantly influenced by bathing water temperatures (p < 0.05) (12). In addition to 
water, non-C. jejuni isolates have been identified among Peruvian children according to 
a study by Schiaffino et al (32). In a children cohort, 917 cultures were speciated as C. 
jejuni (596, 65%) and non-C. jejuni (321, 35%). It is reported that campylobacteriosis is 
a leading cause of pathogenic diarrhea among children under 2 years of age leading to 
weight loss and in children 2 to 5 years old a decrease in height (16, 17, 25, 26, 32). 
Antibiotic Resistance 
 PCR confirmed samples (n=161) were tested for antibiotic resistance (Table 3.3). 
Fifty-three samples (33%) could not proliferate within the SENSITIRE CAMPY2 plates, 
indicating susceptibility to the lowest concentrations of antimicrobials evaluated, while 
67% (n=108) expressed antibiotic susceptibility, intermediate growth, or resistance 
according to the CLSI guidelines within the 2010 NARMS Executive Summary (Table 
3.4) (42).  
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 Ninety-five (59%) isolates expressed resistance or an inability to hinder bacterial 
growth in vitro to at least one antibiotic at therapeutic doses (Tables 3.3 and 3.4) (29). 
According to the 2010 NARMS Executive Summary, erythromycin resistance has 
remained around 4%, ciprofloxacin resistance remained ≥20%, and gentamicin around 
1%. In comparison to the NARMS Summary, the current study found highest resistance 
to clindamycin (47%) followed by nalidixic acid (43%) (42). Twenty-three (14%) isolates 
were resistant to one antibiotic, 27 (17%) isolates were resistant to two, 18 (11%) were 
resistant to three, 12 (7%) were resistant to four, three (2%) were resistant to five, four 
(2%) were resistant to six, and five (3%) were resistant to seven (Figure 3.3). Three 
isolates, all collected on July 28, 2018, at sites B (2) and C, expressed resistance to all 
eight antibiotics. Four isolates [Site B (7/28/18), Site B (7/28/18), Site C (7/28/18), Site 
D (8/12/18)] were resistant to the three antibiotics (erythromycin, ciprofloxacin, and 
tetracycline), which are commonly prescribed for campylobacteriosis (Figure 3.4) (6). 
These isolates indicate dissemination throughout the Tennessee River in Blount and 
Knox Counties, TN. These results are similar to research conducted by Rutledge et al 
and Van Dyke et al (30, 44). Rutledge et al (30) which identified 26 Campylobacter 
positive isolates at seven sites throughout Guildford Co, North Carolina during a two-
year window, attributed to the migration of Canadian geese. Van Dyke et al (44) 
identified 394 Campylobacter isolates within five collection sites throughout the Grand 
River watershed in Ontario, Canada over three years. While these studies were longer 
than the one-year time frame of our study, all studies indicate the likelihood of isolates 
traveling throughout watersheds. 
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Bolinger and Kathariou revealed macrolide (azithromycin and erythromycin) 
resistance to be common among C. coli isolates; however, of the nine isolates resistant 
to both macrolides, none of the isolates were speciated as C. coli (3). Lastly, Schiaffino 
et al (32) studied 596 isolates of which 59.1% were found to be multi-drug resistant 
(MDR). In this current study, 73 (45%) isolates were identified as MDR.  
 
Conclusion  
 This study has substantiated the survival of Campylobacter spp. in river surface 
water throughout the year, indicating that water can act as an important reservoir for 
disseminating Campylobacter spp. Additionally, this study shows multiple-antibiotic 
resistance amongst Campylobacter spp., which can both complicate medical treatment, 
if the organism is capable of causing infections, or serve as a reservoir for antibiotic-
resistant genetic elements that can be disseminated to other microorganisms present 
within the environment. Further evaluation of the public health importance of non-C. 
jejuni, coli, and lari Campylobacter should be determined through whole genome 
sequencing and in vivo analysis to better characterize what virulence elements these 
organisms have and if they are able to cause diarrheal or other illnesses. 
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Dissertation Conclusion 
 
Campylobacter spp. remain a threat to public health and the food industry as a 
leading cause of bacterial foodborne illness. This study identified the presence of 
Campylobacter spp. within previously undocumented food stuffs, such as sprouts and 
microgreens, and in animal feces, such as swine. Additionally, this study provided a 
better understanding of the spatiotemporal distribution of Campylobacter spp. and the 
possibility of surface water serving as a vehicle for campylobacteriosis, especially 
sporadic cases with no epidemic link. Part one of this study indicated antibiotic resistant 
Campylobacter spp. present in surface waters, animal feces, and sprouted seeds within 
the greater East Tennessee geographical region. Part two of this study indicated the 
presence of antibiotic resistant Campylobacter spp. within the surface waters of the 
Tennessee River within Blount and Knox Counties. Both of these could result in 
negative implications for treatment and overall health complications for the region. 
By completing this study, a need to update campylobacteriosis risk factors, 
prevention education, and future treatment options has been identified, especially 
among TDH surveillance areas.  
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Table 1.1. Currently recognized Campylobacter species and associated hosts 
modified from Ngulukun (33) 
Species and Subspecies Host 
C. fetus  
 fetus Cattle, sheep 
 venerealis Cattle, sheep 
C. jejuni  
 jejuni Poultry, cattle, humans 
 doylei Humans 
C. coli  Pigs 
C. concicsus Humans 
C. carvus Humans 
C. hyopinestinalis  
 hyoinestinalis Pigs, cattle, humans 
 lawsonii Pigs 
C. lari   
 lari Seagulls, dogs, humans 
 concheus Humans, shellfish 
C. rectus Humans 
C. upsaliensis Cats, dogs, monkeys 
C. helveticus Cats, dogs 
C. gracilis Humans 
C. showae Humans 
C. sputorum Cattle, pigs, humans 
C. lanienae Pigs 
C. hominis Humans 
C. mucosalis Pigs 
C. insulaenigrae Seals, porpoise 
C. canadensis Wild birds 
C. cuniculorum Rabbits 
C. peloridis Humans, mollusks 
C. avium Poultry 
C. ureolyticus Humans 
C. volucris Wild birds, humans 
C. subantarcticus Wild birds 
C. troglodytis Chimpanzees 
C. corcagiensis Captive lion-tailed macaques 
C. iquaniorum Lizards, chelonians 
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Figure 2.1 Hiwassee River Water Collection Site E and Tennessee Rivers Water Collection Sites 
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Figure 2.2. Prevalence of confirmed Campylobacter spp. among locally collected food, 
fecal, and water samples from March 2017-August 2017 
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Table 2.1. PCR primer sequences selected from Saiyudthong et al, 2015 (26) 
 Primer Sequence (5’ to 3’) Size (bp) 
Campylobacter Campy-F GGA GGC AGC AGT AGG GAA TA 1,062 
 Campy-R TGA CGG GCG GTG AGT ACA AG  
C. jejuni Jejuni-F CAT CTT CCC TAG TCA AGC CT 773 
 Jejuni-R AAG ATA TGG CTC TAG CAA GAC  
C. coli Coli-F GGT ATG ATT TCT ACA AAG CGA G 502 
 Coli-R ATA AAA GAC TAT CGT CGC GTG  
C. lari Lari-F TAG AGA GAT AGC AAA AGA GA 251 
 Lari-R TAC ACA TAA TAA TCC CAC CC  
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Table 2.2. PCR reaction well components 
AmpliTaq Gold Fast PCR, UP 10 μL 
Forward Primer 2 μL 
Reverse Primer 2 μL 
dH2O 5 μL 
Sample extracted DNA 1 μL 
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Table 2.3. Minimal Inhibitory Concentrations (MICs) of Campylobacter spp. confirmed samples using Sensitire CAMPY2 plates 
Isolate SampleA MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
  Aminoglycosides Lincosamides Macrolides Phenicols Quinolones Tetracyclines   
GEN CLI AZI ERY FFND CIP NAL TET 
C. coli SF ngE 4 I 0.5 S 2 S 1 S 0.5 S >64 R 2 S 
C. coli SF ng ng ng ng ng ng ng ng 
C. coli SF ng 2 S 0.12 S 1 S 1 S 0.12 S 16 S 2 S 
C. coli SF ng ng ng ng ng ng ng ng 
C. coli SF 64 R 32 R 2 S 32 R >64 R 64 R >64 R >64 R 
C. coli SF ng ng ng ng ng ng ng ng 
C. coli SF ng ng ng ng ng ng ng ng 
C. coli SF ng ng ng ng ng ng ng ng 
C. coli SF ng 2 S 0.06 S 1 S 1 S 0.06 S 8 S 16 R 
C. jejuni CF ng ng ng ng ng ng ng ng 
Campy spp CF ng 32 R 1 S 16 I 4 S ng 64 R 1 S 
Campy spp CF ng ng ng ng ng ng ng ng 
Campy spp CF ng ng ng ng ng ng ng ng 
Campy spp CF ng ng ng ng ng ng ng ng 
Campy spp GF ng ng ng ng ng ng ng ng 
Campy spp GF 4 I 32 R >64 R >64 R 4 S 32 R >64 R >64 R 
Campy spp GF 8 R 32 R 2 S 32 R 64 R ng 8 S 64 R 
Campy spp MG ng ng ng ng ng ng ng ng 
Campy spp MG ng ng ng ng ng ng ng ng 
Campy spp MG ng ng ng ng ng ng ng ng 
Campy spp MG 1 S 2 S 0.5 S 16 I 2 S 0.12 S 64 R 2 S 
Campy spp MG ng ng ng ng ng ng ng ng 
Campy spp SF ng 16 R 1 S 8 S 8 R ng ng 16 R 
Campy spp Site C ng 4 I 0.12 S 1 S 4 S 0.12 S 16 S 1 S 
Campy spp Site C ng ng ng ng ng ng ng ng 
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Table 2.3 Continued 
Isolate SampleA MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
  Aminoglycosides Lincosamides Macrolides Phenicols Quinolones Tetracyclines 
  GEN CLI AZI ERY FFND CIP NAL TET 
Campy spp Site C 2 S 32 R 0.25 S 1 S 1 S 0.12 S 64 R 1 S 
Campy spp Site C ngE 4 I 0.25 S 4 S 2 S 0.12 S 16 S 1 S 
Campy spp Site C ng ng ng ng ng ng ng ng 
Campy spp Site C ng ng ng ng ng ng ng ng 
Campy spp Site C ng 2 S 0.12 S 1 S 1 S 0.5 S 16 S 1 S 
Campy spp Site C ng 2 S 0.06 S 0.25 S 0.12 S 0.25 S 16 S ng 
Campy spp Site E 1 S 4 I 0.25 S 4 S 4 S 0.5 S 32 I 2 S 
Campy spp Site E ng 4 I 0.25 S 4 S 8 R 0.12 S 16 S 64 R 
Campy spp Site E ng ng 0.12 S 4 S 4 S 0.12 S 16 S 2 S 
Campy spp Site E ng ng ng ng ng ng ng ng 
Campy spp Site E ng ng ng ng ng ng ng ng 
Campy spp Site E ng 2 S 0.25 S 2 S 1 S 0.5 S >64 R 2 S 
Campy spp SP ng ng ng ng ng ng ng ng 
Campy spp SP ng 4 I 0.25 S 4 S 0.5 S ng 16 S 4 S 
ASample codes – CF (cattle feces), GF (geese feces), MG (microgreen), SF (swine feces), SP (sprout), Site C (river water), Site E (river water) 
BAZI (azithromycin), CIP (ciprofloxacin), ERY (erythromycin), FFN (florfenicol), TET (tetracycline), GEN (gentamicin), NAL (nalidixic acid), CLI (clindamycin) 
C Breakpoints were adopted from Clinical and Laboratory Standards Institute (CLSI) as reported in (35), R (resistant), I (intermediate), S (susceptible). 
DFlorfenicol resistance breakpoint not established by CLSI, >8µg/mL established for resistance based upon NARMS reporting. 
ENo growth observed, indicting susceptibility to the lowest concentration of antibiotic tested AZI (0.015), CIP (0.015), CLI (0.03), ERY (0.03), FFN (0.03), TET 
(0.06), GEN (0.12), NAL (4) 
FBolded values indicate resistance. 
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Table 2.4. Campylobacter positive isolates antibiotic susceptibility according to the 
Clinical Laboratory Standards Institute (CLSI) 
Antimicrobial 
Class 
Antimicrobial 
Agent 
Breakpoint 
MIC (µg/mL) 
% (no.) 
Campylobacter spp. 
Aminoglycosides Gentamicin SA ≤ 2 8 (3) 
  I 4 3 (1) 
  R ≥ 8 5 (2) 
Lincosamides Clindamycin S ≤ 2 15 (6) 
  I 4 15 (6) 
  R ≥ 8 15 (6) 
Macrolides Azithromycin S ≤ 2 46 (18) 
  I 4 0 (0) 
  R ≥ 8 3 (1) 
 Erythromycin S ≤ 8 36 (14) 
  I 16 5 (2) 
  R ≥ 32 8 (3) 
Phenicols Florfenicol S ≤ 4 38 (15) 
  I N/A 0 (0) 
  R N/AB 10 (4) 
Quinolones Ciprofloxacin S ≤ 1 33 (13) 
  I 2 0 (0) 
  R ≥ 4 5 (2) 
 Nalidixic Acid S ≤ 16 26 (10) 
  I 32 3 (1) 
  R ≥ 64 18 (7) 
Tetracyclines Tetracycline S ≤ 4 31 (12) 
  I 8 0 (0) 
  R ≥ 16 15 (6) 
AMIC breakpoints – susceptible (S), intermediate (I), resistant (R) 
BFlorfenicol resistance breakpoint not established by CLSI, >8µg/mL established for resistance based 
upon NARMS reporting. 
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Figure 3.1. Tennessee River Water Collection Sites A, B, C, and D
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Figure 3.2. Mean separation of Campylobacter species log CFU/100mL at Site C from 
November 2017 to November 2018  
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Figure 3.3. Mean separation of Campylobacter species log CFU/100mL at Sites A, B, C, 
and D from July 2018 to November 2018 
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Figure 3.4. Campylobacter positive isolates expressing resistance as defined by Clinical 
and Laboratory Standards Institute (CLSI) to tested antibiotics on Sensitire CAMPY2 
plates (n=95) (azithromycin, ciprofloxacin, erythromycin, florfenicol, tetracycline, gentamicin, nalidixic 
acid, clindamycin) 
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Table 3.1. PCR primer sequences selected from Saiyudthong et al, 2015 (31) 
 Primer Sequence (5’ to 3’) Size (bp) 
Campylobacter Campy-F GGA GGC AGC AGT AGG GAA TA 1,062 
 Campy-R TGA CGG GCG GTG AGT ACA AG  
C. jejuni Jejuni-F CAT CTT CCC TAG TCA AGC CT 773 
 Jejuni-R AAG ATA TGG CTC TAG CAA GAC  
C. coli Coli-F GGT ATG ATT TCT ACA AAG CGA G 502 
 Coli-R ATA AAA GAC TAT CGT CGC GTG  
C. lari Lari-F TAG AGA GAT AGC AAA AGA GA 251 
 Lari-R TAC ACA TAA TAA TCC CAC CC  
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Table 3.2. PCR reaction well components 
AmpliTaq Gold Fast PCR, UP 10 μL 
Forward Primer 2 μL 
Reverse Primer 2 μL 
dH2O 5 μL 
Sample extracted DNA 1 μL 
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Table 3.3. Minimal Inhibitory Concentrations (MICs) of Campylobacter spp. confirmed samples using Sensitire CAMPY2 plates 
Isolate Collection 
SiteA 
MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
Aminoglycoside Lincosamide Macrolides Phenicol Quinolones Tetracycline 
GEN CLI AZI ERY FFND CIP NAL TET 
C. coli C ngE ng ng ng ng ng ng ng 
C. coli C ng 16 RF 0.25 S 8 S 4 S 1 S ng 2 S 
C. coli C 8 R 8 R 0.5 S 16 I 0.5 S 1 S >64 R 2 S 
C. coli C ng ng ng ng ng ng ng ng 
C. coli C ng 0.5 S 1 S ng ng 0.5 S ng ng 
Campy spp A >32 R >16 R 1 S 64 R >64 R 16 R >64 R >64 R 
Campy spp A ng >16 R 2 S 32 R 16 R 0.12 S 32 I 4 S 
Campy spp A ng >16 R 4 I 32 R 16 R 0.25 S >64 R 2 S 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A 2 S 2 S 4 I 0.5 S 2 S 2 I >64 R 1 S 
Campy spp A 0.5 S 16 R 2 S 32 R 16 R ng >64 R 2 S 
Campy spp A >32 R >16 R 4 I 32 R 16 R 0.12 S 32 I 2 S 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A 8 R >16 R 4 I 32 R 2 S 0.5 S 32 I 1 S 
Campy spp A 8 R >16 R 4 I 4 S 16 R 1 S 64 R 4 S 
Campy spp A ng 4 I 0.12 S 1 S 8 R 0.25 S 32 I 2 S 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A 16 R >16 R 16 R 64 R 8 R 4 R >64 R 8 I 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A ng ng ng ng ng ng ng ng 
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Table 3.3. Continued 
Isolate Collection 
SiteA 
MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
  Aminoglycoside Lincosamide Macrolides Phenicol Quinolones Tetracycline 
  GEN CLI AZI ERY FFND CIP NAL TET 
Campy spp A ngE 16 R 0.25 S 4 S 32 R 0.12 S 32 I 4 S 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A ng ng 0.06 S 0.12 S 2 S 0.25 S >64 R 0.5 S 
Campy spp A 0.5 S 4 I 1 S 4 S 1 S 1 S >64 R 0.5 S 
Campy spp A 0.25 S 4 I 1 S 8 S 2 S 0.12 S 16 S 0.12 S 
Campy spp A ng ng ng ng ng ng ng ng 
Campy spp A 0.25 S >16 R 1 S 16 I 4 S 0.25 S 32 I 16 R 
Campy spp A 0.5 S 4 I 2 S 4 S 1 S 0.5 S 64 R 0.5 S 
Campy spp A 0.25 S 2 S 2 S 4 S 2 S 0.5 S >64 R 4 S 
Campy spp B >32 R >16 R 0.5 S 2 S 2 S 0.25 S 64 R 4 S 
Campy spp B >32 R >16 R 4 I 32 R 8 R 0.06 S 32 I 2 S 
Campy spp B >32 R >16 R 16 R 64 R 8 R 0.5 S >64 R 4 S 
Campy spp B 0.25 S 8 R 0.25 S 1 S 2 S 0.12 S >64 R 2 S 
Campy spp B >32 R >16 R >64 R >64 R >64 R >64 R >64 R >64 R 
Campy spp B >32 R >16 R >64 R >64 R >64 R >64 R >64 R >64 R 
Campy spp B 0.5 S >16 R 8 R 32 R 16 R 0.12 S 64 R 2 S 
Campy spp B 2 S 4 I 0.5 S 4 S 4 S 8 R >64 R 2 S 
Campy spp B ng 4 I 0.25 S 4 S 4 S 0.12 S >64 R 2 S 
Campy spp B 0.5 S >16 R 2 S 16 I 16 R 0.03 S >64 R 4 S 
Campy spp B 1 S 16 R 0.25 S 4 S 1 S 1 S >64 R 4 S 
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Table 3.3 Continued 
Isolate Collection 
SiteA 
MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
  Aminoglycoside Lincosamide Macrolides Phenicol Quinolones Tetracycline 
  GEN CLI AZI ERY FFND CIP NAL TET 
Campy spp B ngE 8 R 1 S 4 S 16 R 0.12 S 32 I 4 S 
Campy spp B ng >16 R 2 S 32 R 16 R 0.25 S >64 R 4 S 
Campy spp B ng 4 I 0.12 S 1 S 8 R 0.06 S 64 R 2 S 
Campy spp B 8 R >16 R 2 S 32 R 16 R 1 S 64 R 16 R 
Campy spp B 1 S 8 R 0.06 S 2 S 4 S 0.12 S >64 R 4 S 
Campy spp B ng ng ng ng ng ng ng ng 
Campy spp B ng ng ng ng ng ng ng ng 
Campy spp B ng ng ng ng ng ng ng ng 
Campy spp B 16 R >16 R 4 I 32 R 32 R 4 R 64 R 8 I 
Campy spp B ng ng ng ng ng ng ng ng 
Campy spp B ng ng ng ng ng ng ng ng 
Campy spp B 2 S >16 R 2 S 8 S 4 S 2 I >64 R 16 R 
Campy spp B 0.25 S 16 R 0.5 S 4 S 16 R 0.12 S 16 S 2 S 
Campy spp B 1 S 4 I 0.5 S 8 S 2 S 0.12 S 8 S 0.25 S 
Campy spp B ng ng ng ng ng ng ng ng 
Campy spp B 1 S 8 R 2 S 16 I 2 S 0.25 S 32 I 0.25 S 
Campy spp B 0.5 S 2 S 4 I 4 S 2 S 1 S >64 R 2 S 
Campy spp C ng >16 R 2 S 8 S 2 S 1 S ng 8 I 
Campy spp C >32 R >16 R 2 S 8 S 4 S 2 I 32 I 8 I 
Campy spp C 16 R >16 R 2 S 8 S 4 S 2 I 16 S 8 I 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng 1 S 
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Table 3.3. Continued 
Isolate Collection 
SiteA 
MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
  Aminoglycoside Lincosamide Macrolides Phenicol Quinolones Tetracycline 
  GEN CLI AZI ERY FFND CIP NAL TET 
Campy spp C 8 R >16 R 2 S 4 S 4 S 4 R 32 I 4 S 
Campy spp C ngE ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C 8 R 8 R 0.5 S 16 I 0.5 S 1 S >64 R 4 S 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C 0.25 S 8 R 1 S 16 I 4 S 0.25 S >64 R 64 R 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C 0.5 S 2 S 0.5 S 4 S 4 S 0.5 S 8 S 4 S 
Campy spp C ng 2 S 2 S 2 S 1 S 0.5 S >64 R 2 S 
Campy spp C ng 4 I 0.25 S 4 S 2 S 0.12 S 32 I 1 S 
Campy spp C 4 I 1 S 0.03 S 2 S 1 S 1 S 64 R 2 S 
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Table 3.3 Continued 
Isolate Collection 
SiteA 
MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
  Aminoglycoside Lincosamide Macrolides Phenicol Quinolones Tetracycline 
  GEN CLI AZI ERY FFND CIP NAL TET 
Campy spp C ngE 2 S 0.06 S 0.25 S 0.12 S 0.12 S 32 I 0.25 S 
Campy spp C ng 1 S 0.03 S 0.25 S 1 S 0.12 S 32 I 2 S 
Campy spp C 0.5 S 8 R 0.12 S 1 S 4 S 0.25 S 64 R 4 S 
Campy spp C 0.25 S 8 R 0.12 S 1 S 4 S 0.12 S 32 I 4 S 
Campy spp C 0.25 S 16 R 0.25 S 2 S 4 S 0.25 S 64 R 2 S 
Campy spp C 0.12 S >16 R 4 I >64 R 32 R 0.25 S >64 R >64 R 
Campy spp C 0.25 S 4 I 1 S 2 S 1 S 1 S 32 I 0.5 S 
Campy spp C 4 I >16 R 0.5 S 4 S 32 R 0.12 S 32 I 4 S 
Campy spp C ng 2 S 0.25 S 1 S 2 S 1 S >64 R 8 I 
Campy spp C 2 S >16 R 1 S 4 S 2 S 0.5 S >64 R 2 S 
Campy spp C 2 S >16 R 0.5 S 8 S 4 S 0.5 S >64 R 4 S 
Campy spp C 2 S 8 R 0.25 S 1 S 8 R 1 S >64 R 8 I 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C >32 R >16 R >64 R >64 R >64 R >64 R >64 R >64 R 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C 1 S >16 R 0.5 S 8 S 1 S 0.12 S 32 I 1 S 
Campy spp C 0.5 S >16 R >64 R 16 I 8 R 0.12 S >64 R 4 S 
Campy spp C ng 8 R 0.25 S 2 S 16 R 0.12 S 16 S 4 S 
Campy spp C ng >16 R 4 I 32 R 32 R 0.12 S 32 I 4 S 
Campy spp C ng 16 R 0.25 S 2 S 8 R 0.5 S 32 I 2 S 
Campy spp C ng >16 R 2 S 16 I 16 R 0.06 S >64 R 4 S 
Campy spp C ng >16 R 2 S 32 R 16 R 0.03 S >64 R 4 S 
Campy spp C >32 R >16 R 4 I 32 R 16 R 32 R >64 R 16 R 
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Table 3.3 Continued 
Isolate Collection 
SiteA 
MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
  Aminoglycoside Lincosamide Macrolides Phenicol Quinolones Tetracycline 
  GEN CLI AZI ERY FFND CIP NAL TET 
Campy spp C 0.5 S 16 R 1 S 2 S 1 S 0.03 S >64 R 2 S 
Campy spp C 0.25 S 4 I 2 S 2 S 2 S 0.06 S >64 R 1 S 
Campy spp C ngE ng ng ng ng ng ng ng 
Campy spp C ng 16 R 0.12 S 4 S 16 R 0.12 S 32 I 4 S 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng 16 R 0.5 S 4 S 32 R 0.25 S 64 R 16 R 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C 0.5 S >16 R 0.25 S 4 S 4 S 0.12 S 32 I 0.5 S 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng ng ng ng ng ng ng ng 
Campy spp C ng 4 I 0.25 S 4 S 8 R 0.12 S 32 I 4 S 
Campy spp C 2 S 16 R 4 I 32 R 4 S 0.5 S >64 R 2 S 
Campy spp C 1 S 8 R 1 S 1 S 4 S 0.5 S >64 R 0.25 S 
Campy spp C ng 4 I 0.5 S 4 S 1 S 0.25 S 32 I 0.25 S 
Campy spp C 1 S 4 I 0.25 S 1 S 0.25 S 0.5 S 32 I 4 S 
Campy spp C 0.25 S >16 R 2 S 8 S 4 S 0.5 S >64 R 1 S 
Campy spp C ng 8 R 0.5 S 1 S 0.25 S 0.5 S >64 R 0.25 S 
Campy spp D 0.5 S 1 S 1 S 1 S 1 S 0.25 S 16 S 1 S 
Campy spp D ng >16 R 0.12 S 4 S 2 S 0.25 S >64 R 8 I 
Campy spp D 1 S 1 S 0.12 S 1 S 1 S 0.12 S >64 R 0.5 S 
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Table 3.3 Continued 
Isolates Collection 
SiteA 
MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
  Aminoglycoside Lincosamide Macrolides Phenicol Quinolones Tetracycline 
  GEN CLI AZI ERY FFND CIP NAL TET 
Campy spp D 1 S 2 S 0.12 S 1 S 4 S 0.5 S >64 R 0.5 S 
Campy spp D 0.5 S >16 R 8 R 64 R 16 R 2 I >64 R 8 I 
Campy spp D 4 I 16 R 1 S 8 S 16 R 0.25 S >64 R 2 S 
Campy spp D 0.5 S >16 R 2 S 8 S 64 R 4 R >64 R 8 I 
Campy spp D >32 R >16 R 32 R 32 R 64 R 4 R 32 I 64 R 
Campy spp D ngE ng ng ng ng ng ng ng 
Campy spp D ng >16 R 2 S 32 R 16 R 0.25 S >64 R 4 S 
Campy spp D ng ng ng ng ng ng ng ng 
Campy spp D 8 R 4 I 0.5 S 4 S 2 S 0.25 S >64 R 16 R 
Campy spp D 1 S 8 R >64 R 2 S 0.25 S 1 S >64 R 1 S 
Campy spp D 2 S 16 R 0.5 S 1 S 0.5 S 0.5 S 32 I 1 S 
Campy spp D ng 16 R 0.25 S 2 S 8 R 0.12 S 64 R 4 S 
Campy spp D 0.5 S ng 0.25 S 0.5 S 0.5 S 8 R >64 R 1 S 
Campy spp D ng ng ng ng ng ng ng ng 
Campy spp D ng ng ng ng ng ng ng ng 
Campy spp D >32 R >16 R 16 R >64 R 32 R 0.06 S 64 R 4 S 
Campy spp D >32 R >16 R 2 S 16 I 16 R 2 I >64 R 8 I 
Campy spp D 4 I >16 R 0.5 S 8 S 4 S 1 S >64 R 16 R 
Campy spp D >32 R >16 R 4 I 32 R 16 R 8 R >64 R 64 R 
Campy spp D 1 S >16 R 0.12 S 8 S 4 S 0.5 S 64 R 4 S 
Campy spp D 1 S 16 R 2 S 8 S 2 S 2 I 32 I 0.5 S 
Campy spp D 0.5 S 4 I 0.5 S 2 S 1 S 0.12 S 32 I 0.12 S 
Campy spp D 1 S 8 R 4 I 8 S 4 S 0.5 S 64 R 2 S 
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Table 3.3 Continued 
Isolates Collection 
SiteA 
MIC (µg/mL)B and Antibiotic SusceptibilityC 
(Drug Class) 
  Aminoglycoside Lincosamide Macrolides Phenicol Quinolones Tetracycline 
  GEN CLI AZI ERY FFND CIP NAL TET 
Campy spp D 0.5 S 1 S ngE 0.25 S 0.25 S ng 32 I 4 S 
Campy spp D 1 S 4 I 0.25 S 2 S 1 S 1 S >64 R 1 S 
Campy spp D 0.5 S 8 R 2 S 16 I 1 S 0.5 S >64 R 2 S 
ASample codes – A (river water), B (river water), C (river water), Site D (river water) 
BAZI (azithromycin), CIP (ciprofloxacin), ERY (erythromycin), FFN (florfenicol), TET (tetracycline), GEN (gentamicin), NAL (nalidixic acid), CLI 
(clindamycin) 
C Breakpoints were adopted from Clinical and Laboratory Standards Institute (CLSI) as reported in (37), R (resistant), I (intermediate), S 
(susceptible). 
DFlorfenicol resistance breakpoint not established by CLSI, >8µg/mL established for resistance based upon NARMS reporting. 
ENo growth observed, indicting susceptibility to the lowest concentration of antibiotic tested AZI (0.015), CIP (0.015), CLI (0.03), ERY (0.03), 
FFN (0.03), TET (0.06), GEN (0.12), NAL (4) 
FBolded values indicate resistance. 
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Table 3.4. Campylobacter positive isolates antibiotic susceptibility according to the 
Clinical and Laboratory Standards Institute (CLSI) 
Antimicrobial 
Class 
Antimicrobial 
Agent 
Breakpoint 
MIC (µg/mL) 
% (no.) 
Campylobacter spp. 
Aminoglycosides Gentamicin SA ≤ 2 32 (52) 
  I 4 2 (4) 
  R ≥ 8 14 (23) 
Lincosamides Clindamycin S ≤ 2 9 (14) 
  I 4 10 (17) 
  R ≥ 8 47 (75) 
Macrolides Azithromycin S ≤ 2 51 (82) 
  I 4 9 (14) 
  R ≥ 8 7 (11) 
 Erythromycin S ≤ 8 44 (71) 
  I 16 6 (10) 
  R ≥ 32 16 (26) 
Phenicols Florfenicol S ≤ 4 39 (63) 
  I N/A 0 (0) 
  R N/AB 27 (44) 
Quinolones Ciprofloxacin S ≤ 1 54 (87) 
  I 2 4 (6) 
  R ≥ 4 8 (13) 
 Nalidixic acid S ≤ 16 4 (7) 
  I 32 18 (29) 
  R ≥ 64 43 (70) 
Tetracyclines Tetracycline S ≤ 4 52 (84) 
  I 8 6 (9) 
  R ≥ 16 9 (15) 
AMIC breakpoints – susceptible (S), intermediate, (I), resistant (R) 
BFlorfenicol resistance breakpoint not established by CLSI, >8µg/mL established for resistance based 
upon NARMS reporting. 
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